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Abstract
Metabolic flux analysis (MFA) is a technique used to elucidate intracellular reac-
tion rates (fluxes) in a metabolic network. Intracellular fluxes are determined by pro-
viding substrate enriched with stable, heavy isotopic label and subsequently measur-
ing the incorporation of label into metabolic end products. This results in metabolic
end products consisting of isomers of discrete mass states, termed isotopomers. The
resulting isotopomer distributions (MIDs) for each metabolic end product are then
used to infer fluxes.
Typically, metabolic end products used for MFA are derivatized protein-bound
amino acids. Protein is extracted from the sample and hydrolyzed into constitutive
amino acids, resulting in a amino acid pools derived from all cellular protein. Each
amino acid pool contains amino acids potentially synthesized from di↵erent subcel-
lular compartments, subspecies within a culture, or from di↵erent time points within
the cell cycle. Thus, fluxes inferred from hydrolyzed total protein lack spatial and
temporal resolution. However, if amino acid MIDs were to be measured directly
from individual proteins, one could derive the fluxes at the time and place for which
that particular protein was synthesized. Therefore, obtaining amino acid MIDs from
individual proteins could enable spatial and temporal resolution for metabolic flux
analysis. One solution would be to purify individual protein and hydrolyze and mea-
sure amino acid MIDs. This approach would require a significant amount of protein,
is manually intensive and expensive. A much more viable solution utilizes high-
throughput and high-resolution mass spectrometry to quantify and identify peptide
MIDs, which can be used to infer constitutive amino acid MIDs. However, there is no
well-defined, automated framework for the extraction and quantification of peptide
iii
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MIDs from raw mass spectra.
In the first chapter, the conceptual framework and vocabulary need for mass spec-
trometry and peptide-based MFA are provided, with a statistical emphasis. Chapter
2 provides a review of proteomics instrumentation for peptide based MFA followed
by the algorithmic considerations and potential software solutions available for the
extraction of peptide MIDs.
Chapter 3 will describe the methods developed for the automated extraction and
quantification of isotopically enriched peptides, including parameter optimization of
existing methods and description of novel clustering and quantification methods.
Chapter 4 describes the validation of the methods using three di↵erent sets of la-
beled peptide MIDs. Chapter 5 provides a brief discussion of method and software
improvements for both identification and quantification followed by a brief discussion
of future work.
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Chapter 1
Preliminaries
The resurgence of central carbon metabolism as an active area of research has been
motivated by a variety of scientific goals within the 21st-century, ranging from the
e cient production of biofuels to the characterization of cancer physiology (Clomburg
and Gonzalez, 2010) (Keibler et al., 2012) . More fundamentally, an overarching goal
in systems biology is to characterize the underlying metabolic response to genetic
and environmental perturbations. Studying cellular metabolism from a systems level
allows researchers to understand the underlying physiology for a given phenotype.
Although the biochemical characteristics of metabolic enzymes are well established
in vitro, the development of tools and techniques aimed at characterizing cellular
metabolism in vivo are ongoing, and primarily rely on measuring the outputs of a
metabolic network after the incorporation of isotopically enriched (labeled) substate
(Wiechert, 2001). In this chapter, a description of the vocabulary and concepts
associated with the use of stable isotope labeling to study metabolism is provided.
1.1 Isotopomers and Mass Distributions
For any given molecule, the collection of isotopic isomers are defined as positional
isotopomers. Each positional isotopomer can be partitioned by mass state into
1
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Figure 1.1: 3 atom molecule with 2 discrete mass states (black and white); A. Posi-
tional Isotopomers, B. Mass Isotopomers, C. Isotopologues



groups called mass isotopomers. For example, suppose we have a molecule with 3
atoms, where each atom existed in 2 distinct mass states. This molecule can exist in
23 = 8 di↵erent atomic positional configurations. (see Figure 1.1). However, when
grouping the set of positional isotopomers by mass, only four unique mass states are
observed. Furthermore, we can define the mass state of a particular molecule to be a
discrete random variable, X sampled from a discrete sample space of possible mass
states,  . It is conventional to define each mass isotopomer as m+i, where i are the
number of heavy labeled atoms. Moreover, we will define   = {0, 1 . . .m}, where m
are the number of atoms within a particular molecule.
For any population of molecules, mass isotopomers are present at specific fre-
quencies. The entire group of isotopic isomers within a sample of this population
are defined as isotopologues, or I. For a given group of isotopologues, frequen-
cies of mass isotopomers can be quantified using mass spectrometry. We can express
mass isotopomer frequencies as a distribution, defined as a mass isotopomer dis-
tribution (MID), which can be expressed in absolute or relative abundances (see
Figure 1.2). Furthermore, we can express absolute or relative MIDs as vectors, I
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Figure 1.2: Collection of isotopologues at specific frequencies: In mass spectrometry
data, mass to charge (m/z ) ratios paired with intensity measurements resolve the
frequencies of mass isotopomers within a group of isotopologues
mass
 I
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and p. The ith element of I and p correspond to the absolute number or the relative
frequency of sampled isotopologues for mass isotopomer m+i, respectively. The ith
element in the relative MID is defined as the relative isotopic abundance (RIA)
for isotopomer m+i, where
pi =
Ii
I (1.1)
From a statistical point of view, we can define the probability of sampling mass
isotopomer m+i as Pr{X = i}, which can be estimated from the relative frequency
of m+i. For example, in Figure 1.2 there are 12 molecules that make up the group of
isotopologues, three of which contain no heavy label (i.e. mass isotopomer m+0). The
probability of sampling m+0 can be estimated from the observed sampling frequency
of m+0, where Pr{X = i} ⇡ p0 = 312 = 0.25. The sampling frequency approximates
the probability when the sample size, I, increases.
By establishing the connection between probability theory and MIDs, it is possible
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to model a MID as a multinomial distribution where the observation of each
molecule is an independent sample resulting in a success for one of many mass states,
with each mass state having a fixed success probability (Casella and Berger, 2001).
For a sample size of I isotopologues, the expected value for mass isotopomer i can
be calculated, such that:
E(X = i) = I Pr{X = i} ⇡ Ipi (1.2)
Additionally, a sampling variance and standard deviation can be estimated using the
following equation:
Var (X = i) ⇡ Ipi(1  pi) and  (X = i) ⇡
p
Ipi(1  pi) (1.3)
Equations (1.2) and (1.3) can be used to simulate isotopomer distributions, errors
and confidence intervals for any isotopologue sample size.
1.2 Mass Spectrometry
The analytical method that resolves MIDs is high resolution mass spectrometry (MS),
where signals proportional to the isotopologue abundance are measured as a function
of mass over charge (m/z ). Populations of ionized isotopologues are sampled simul-
taneously, and current is measured over a period of time. The transient signal is then
converted to the frequency domain using the Fourier transform, where individual fre-
quency measurements correspond with m/z, resulting in isotopically resolved mass
spectra from a single sample. Moreover, liquid chromatography - mass spectrometry
(LC-MS) is a powerful technique that couples the physical separation of molecules in
a temporal domain with highly resolved mass measurements (Scigelova and Makarov,
2006).
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Figure 1.3: MID as a function of time: In mass spectrometry data, MIDs are observed
in multiple sampling events providing; Each isotopomer within a group of isotopo-
logues exhibit di↵erent absolute intensities in time, however maintain the same relative
intensity
m/z
A
bs
ol
ut
e 
Is
ot
op
e 
A
bu
nd
an
ce
tim
e
m/z
R
el
at
iv
e 
 I
so
to
pe
 A
bu
nd
an
ce
tim
e
In LC-MS, isotopologues elute o↵ the column continuously and samples are in-
jected into the mass analyzer at discrete time points, called scan events. A mass
trace is defined as a single m/z measurement observed within contiguous scan events.
Assuming a mass trace contains all measurements for a particular mass isotopomer,
tracking the abundance of a mass trace across multiple scan events is called an ex-
tracted ion chromatogram (EIC). Figure 1.3 is an example of time-dependent
mass spectra obtained from an LC-MS experiment. In this example, di↵erent scan
events are denoted by di↵erent colors, while the collection of intensity measurements
for one mass isotopomer would be the EIC (Yates et al., 2009).
From a statistical point of view, LC allows for multiple samples to be drawn
from the same population of isotopologues, which enables more accurate quantifica-
tion of MIDs. In Figure 1.3 it is shown that although the total number of sampled
mass isotopomers vary through time, the RIA for each isotopomer remains the same.
The temporal invariance of RIAs illustrate that di↵erences in absolute isotopomer
abundances though time is a function of isotopologue sample size, which is heavily
exploited in the automated extraction and quantification of MIDs in Chapter 3.
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1.3 Simulating MIDs
Techniques that use stable isotopes to generate information about the utilization of a
metabolic network require the ability to formulate models of MIDs. Thus, in addition
to rigorous quantification and characterization, the basic principles that are used to
simulate MIDs warrant discussion (Hellerstein and Neese, 1999).
Three basic scenarios arise when attempting to simulate MIDs: (1)mixing of two
isotopologue populations for the same molecule, (2) condensation reactions and (3)
cleavage reactions. Predicted MIDs from mixing and condensation can be solved
analytically, while cleavage reactions require an algorithmic approach. Characteristics
and di↵erences between each scenario are highlighted in the following subsections.
1.3.1 Mixing
Figure 1.4 illustrates the mixing of isotopologue distributions, which is also called
tracer or self-di↵usion. In this example, a two atom molecule initially exhists in
two, separate isotopologue populations, denoted A1 and A2, with MIDs A1 and A2,
respectively. Suppose a third population , A1+2 (with a MID, A1+2) is comprised of
20% of isotopologues originated from A1 and 80% originating from A2. The RIA for
the m+1 mass isotopomer of A1+2 would be determined by adding the m+1 RIAs
for A1 and A2 scaled by the relative proportions of the isotopologues, where
a1,1+2 = 0.20⇥ 0.50 + 0.80⇥ 0 = 0.10
More generally, if we define the population ratio parameter, r, the ith element in
A1+2 can be uniquely determined, such that
ai,1+2 = r ⇥ ai,1 + (1  r)⇥ ai,2 (1.4)
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m+0 m+1
50%
0%
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9%
mixing
m+0 m+1
25%
50%
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25%
80%20%
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10%
m+2
45%
Population A1 Population A2
Figure 1.4: Mixing of Isotopologue Populations: Two isotopologue populations con-
sisting of the same atomic composition are mixed with di↵erent frequencies - 20% of
population A1 is mixed with 80% of A2
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1.3.2 Condensation reactions
If MIDs for substrates involved in an addition reaction are known, then product
MIDs can be calculated using an operation called discrete convolution. Suppose
molecules A and B are substrates in a condensation reaction with MIDs A and B,
respectively. The product, C has a MID, C that can be determined using the following
relationship:
A+B! C =) A ⇤B = C (1.5)
where the ⇤ operation is the convolution operator. An intuitive description of con-
volution is illustrated in Figure 1.5, where substrates in the condensation reaction
consist of a single atom existing in one of two mass states; 70% of the population ex-
ists in the light mass state (m+0) while the remaining 30% is in the heavy mass state
(m+1). Two independent, random samples of individual atoms are drawn from the
precursor pool in a sampling event, polymerized and enter into a product pool. If the
sampling and condensation occur enough times and without bias for a particular mass
state, the RIAs of the product can be calculated based on the sampling probability
of substrates. The entire space of sampling events can be generated and RIAs can be
estimated for all possible product mass isotopomers. For example, synthesizing an
m+1 consisting of one heavy and one light atom can occur in two di↵erent ways - a
heavy atom can be sampled first, followed by a light or visa-versa. The probability
of sampling an m+1 product, p1 could be determined as follows:
p1 = (0.7)(0.3) + (0.3)(0.7) = 0.42
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Discrete convolution can be generalized for arbitrary substrate MIDs A and B
with elements ai and bj, respectively, such that:
c0 = a0b0
c1 = a1b0 + a0b1
c2 = a2b0 + a1b1 + a0b2
...
cn = anb0 + an 1b1 + . . .+ a0bn
(1.6)
where
i > |A| ) ai = 0
j > |B| ) bj = 0
where ck is the kth element in the product MID, C. Additionally, MIDs for molecules
consisting of elements with a fixed probability can also be calculated using a binomial
distribution model, however su↵er when the MID is simulated from substrates with
di↵erent elemental or molecular distributions. A discussion of labeling scenarios is
left for Section 1.4, within the context of isotopic propagation through a metabolic
network.
1.3.3 Cleavage reactions
The third type of reaction is a cleavage reaction, which is of the form:
C! A+B (1.7)
Where the substrate MID, C, is split into product distributions A and B. Determining
product distributions A and B is an inverse problem which requires an algorithm-
based approach to iteratively fit for optimal product MIDs - a processes called de-
convolution (Jansson, 1996). The algorithm first guesses product MIDs, A and B,
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m+0 m+1
70%
30%
m+0 m+1
49%
42%
m+2
9%
polymerization
+
substrate product 
sampling
Figure 1.5: Discrete Convolution of Mass Isotopomer Distributions: Sample of the
substrate population are taken independently, condensed and added to the product
pool. The relative frequency for each product mass isotopomer can be calculated
using discrete convolution
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followed by simulation of substrate C via convolution. An objection function, f is
then used to map the individual di↵erences between measured and simulated RIAs of
C, called residuals into a scalar value representing the quality of fit, called a residuum.
An optimization algorithm (e.g. interior points or sqp) uses a gradient-based search
to either simulate a new set of product MIDs that provide a better fit or terminate if
optimality criteria are satisfied. More compactly, for cleavage reactions, the following
relationship holds:
C! A+B =) minimize
A,B
f(C   A ⇤B) (1.8)
There are situations when A and B can be calculated analytically, however in
practice solutions are confounded when error is introduced in the known distribution
C. Thus, fitting remains the most practical approach when faced with a cleavage
problem.
1.4 Metabolic Labeling
The ultimate motivation for quantifying MIDs is to gain insight on the functional
utilization of a biochemical networks by quantifying the molecular tra c, or fluxes,
through reactions. Examples of substrate labeling conditions have been provided thus
far have only served to illustrate the formulation of MIDs in single reactions, rather
than within the context of fluxes through a metabolic network. To this end, metabolic
end product MIDs are characterized based on two substrate labeling examples given
di↵erent flux scenarios.
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Figure 1.6: Example Metabolic Network: Uniformly labeled glucose enters in the
metabolic network and is partitioned between glycolysis and the pentose phosphate
pathway (PPP). The pyruvate product distribution contains the same elemental la-
beling distributions as the glucose substate, leading to a product MID invariant to
flux distributions
(3) Ribulose-
5-Phosphate
+
(3) C02
(2) Fructose-
5-Phosphate
(3) Fructose-
6-Phosphate
(6) Pyruvate (5)Pyruvate
Glycolysis Pentose Phosphate Pathway
(3) Uniform 13C Glucose
1.4.1 Uniformly Labeled Substrate
Figure 1.6 is an example of a simplified metabolic network for central carbon metabolism.
Three molecules of glucose can either flow through glycoloysis or the pentose phos-
phate pathway (PPP) to produce pyruvate. The rate of flow is defined as flux, v,
where vglyc and vppp represent the molecular flow through glycolysis and PPP, respec-
tively.
If the substrate is uniformly labeled, elements of the same type within the
molecule have equivalent MIDs. Figure 1.6 illustrates this scenario by encoding each
atoms’ fractional abundance of heavy label in greyscale, where black means 100% of
that atom exists in the labeled state and white means 100% of that atom exists in
the unlabeled state.
Regardless of the flux distribution (e.g. vglycvppp ) the metabolic end product can be
expressed as a convolution of elemental MIDs. For example, in Figure 1.6 pyruvate
is generated from both glycolysis and PPP at di↵erent rates (e.g. vglyc 6= vppp), but
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Figure 1.7: Pyruvate MID as a function of di↵erent atomic RIAs: The MID of a
uniformly labeled MID only dependent on the constitutive elemental MIDs.
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contain the same elemental label distributions. Thus, molecular MIDs at any point in
the metabolic network can be expressed as a function of the percentage of elemental
label enrichment (see Figure 1.7).
1.4.2 Positionally Labeled Substrate
Figure 1.8 illustrates a simple labeling experiment done to determine the flux through
glycolysis and the pentose phosphate pathway (PPP) using 13C labeled glucose at the
one position as labeled substrate. When three molecules of glucose pass through gly-
colysis, six molecules of pyruvate are generated. If glucose is labeled at the one
position, two mass isotopomers (m+0 and m+1) of pyruvate are observed in equal
amounts. When three molecules of glucose pass through the pentose phosphate path-
way, five molecules of pyruvate and three molecules of carbon dioxide are generated.
However, when glucose is labeled in the one position, all label is incorporated into
carbon dioxide, leaving only the m+0 mass isotopomer of pyruvate.
Figure 1.9 illustrates the relationship between the pyruvate MID and di↵erent
flux distribution scenarios. In the first case, all flux is directed through glycolysis,
which leads to an equal abundances of the m+0 and m+1 isotopomers, such that
p = [0.5, 0.5, 0, 0]. In the second case all flux is directed through PPP, resulting in
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Figure 1.8: Positional Labeling Within a Metabolic Network
(3) 1-13C Glucose
(3) Ribulose-
5-Phosphate
+
(3) C02
(2) Fructose-
5-Phosphate
(3) Fructose-
6-Phosphate
(3L, 3U) Pyruvate (5U) Pyruvate
Glycolysis Pentose Phosphate Pathway
100% of the isotopologues occupying the m+0 state, or p = [1, 0, 0, 0]. In the third
case, flux is split equally between glycolysis and PPP, resulting in a distribution
that exists in between the first two cases. The distribution can be quantified via a
simple example. Suppose 6 molecules of glucose were distributed equally through
glycosis and PPP, resulting in 3 labeled and 8 unlabeled pyruvate molecules, such
that I = [8, 3, 0, 0] and p = [ 811 ,
3
11 , 0, 0] = [0.73, 0.27, 0, 0].
This simple example illustrates that the metabolic end product MID is uniquely
dependent on the distribution of fluxes, meaning that MIDs cannot be simulated
unless the flux distribution is known a priori.
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Figure 1.9: Pyruvate MID as a function of di↵erent flux distribution scenarios
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1.5 Flux Analysis
1.5.1 13C Metabolic Flux Analysis
Techniques utilizing stable isotopic tracers to elucidate metabolic activiy has matured
over the last decade, most notabily of which being 13C-based metabolic flux analysis
(13C MFA) (Wiechert, 2001). The gaol of 13C MFA is to quantify steady state intra-
cellular reaction rates (fluxes) within a metabolic network, and has become a routine
procedure within the last decade for experimental microbial metabolism (Zamboni
et al., 2009). In this procedure, metabolic fluxes are inferred from isotopic distribu-
tions of proteinogenic amino acids (AAMDs) synthesized from 13C enriched substrate.
Key technological advances have made performing 13C-MFA for central carbon net-
works feasible (Wiechert and de Graaf (1997), Wiechert et al. (1997), Wiechert et al.
(1999), Mo¨llney et al. (1999)) and computationally e cient using the EMU model
(Antoniewicz et al., 2007), where open source computational tools have been become
readily available (Quek et al. (2009),Weitzel et al. (2013)).
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Conceptually, 13C-MFA is performed using the approach presented in Section 1.3.3,
however fluxes are model parameters instead of MIDs. Fluxes are used to simulate
AAMDs ( AAMDsim) and compared to measured AAMDs (AAMDmeas) using a least
squares comparison.
1.5.2 Peptide-based Metabolic Flux Analysis
As reconstructed metabolic networks expand beyond prokaryotic central metabolism
and take into account compartmentalization in eukaryotic organisms (Krumholz et al.,
2012), new experimental techniques aimed at validating these models are required.
Currently 13C-MFA has limitations; derived flux maps of metabolism are spatially and
temporally invariant. Measured distributions are derived from all cellular protein, and
thus contain amino acids synthesized at di↵erent times, sub-cellular compartments
or within di↵erent sub-species. Because protein translation can be a temporally and
spatially regulated process, constitutive AAMDs from specific proteins can report on
metabolism at the time and location of translation.
Experimental techniques have been developed recently to determine spatially-
specific flux maps. For example Allen et al. (2007) used labeling patterns in fatty
acid groups, cell wall components, protein glycans, and starch synthesized in di↵er-
ent compartments of the plant cell to derive compartment-specific flux maps. More
recently, Ru¨hl et al. (2011) measured AAMDs from an engineered GFP reporter to
quantify fluxes from a single species within a microbial consortia.
We recently reported a new proteomics-based approach using peptide MIDs (PMDs)
to quantify fluxes (Mandy et al., 2013). In this technique, a labeling experiment is
performed, followed by protein extraction, gel purification and enzymatic digestion,
resulting in a sample of isotopically enriched peptides. Peptides are separated further
using HPLC followed by quantification of MIDs using high resolution MS. Peptide
MIDs are then integrated into the fitting framework described for classical 13C-MFA
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Figure 1.10: Peptide-based MFA approaches: solid arrows represent forward problems
while dotted lines represent inverse problems. Case(1): PMDs are freely deconvolved
to AAMDs and fluxes are fitted to deconvoved AAMDs. Case(2): Fluxes are fitted
directly to PMDs, resulting in flux-constrained AAMD solutions.
PMDs AAMDs
Fluxes
Deconvolution
Convolution
EMU Model
Flux-
constrained
deconvolution
using the EMU model implemented in OpenFLUXTM. Figure 1.10 shows the two ap-
proaches used for peptide based MFA. In the first case, PMDs are first deconvolved
into constitutive AAMDs, followed by fitting fluxes to deconvolved AAMDs. In the
second case, fluxes are directly fitted to PMDs. While the first case allows AAMDs
to assume any distribution that best fits the PMDs, the second approach constrains
AAMDs with the metabolic network.
The key advantage of peptide-based MFA over other methods is that it utilizes
high-throughput proteomic data. Like other high-throughput techniques, rapid tech-
nical advances are making proteomics experiments more tractable, enabling researches
to produce highly complex proteomic datasets cheaply and quickly. However as
datasets become richer, new algorithmic approaches are required to extract mean-
ingful biological information.
1.6 Scope of this thesis
The scope of this thesis project was to utilize the basic principles of probability theory,
high resolution MS, and isotopic label propagation through metabolic networks to
develop an algorithmic framework and software implementation for the automated
1.6. Scope of this thesis 18
extraction and quantification of PMDs for peptide based metabolic flux analysis. In
the next chapter, a brief discussion of current the instrumentation, algorithmic and
software requirements needed for peptide based MFA are given. The limitations of
algorithms and software designed for the proteomics and metabolomics community is
of central focus and provide motivation for methods developed in Chapter 3.
Chapter 2
Proteomics for Peptide-based MFA
Proteomics is a scientific discipline that has seen rapid development over the last
15 years (Mallick and Kuster, 2010). In addition to advances in technology aimed
at high-throughput peptide sequencing in complex biological samples, a variety of
techniques have been developed to obtain quantitative information using stable iso-
topic labeling both in vitro and in vivo (Bantsche↵ et al. (2007), Bantsche↵ et al.
(2012)). Comprehensive overviews of key technologies and techniques that capture
the evolution of the field are vast and are beyond the scope of this thesis. Instead,
it is imperative that we describe the instrument and software specifications required
for the experimental design of peptide-based MFA, while simultaneously highlighting
di↵erences between current techniques and algorithms used for the high-throughput
quantitative proteomics experiments.
This chapter first provides an overview of the instrumentation required for peptide-
based MFA with a description of the data generated after an experiment is performed.
Next, di↵erent techniques used in quantitative proteomics are described, highlighting
the di↵erences between the data produced using these techniques and data generated
from a flux analysis experiment. Next a review of algorithms and software is provided,
with an emphasis on frameworks available for the automated extraction of isotopically
enriched proteomics datasets.
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2.1 Instrumentation: Orbitrap
Peptide-based MFA requires instrumentation that is capable of quantifying RIAs for
an unknown number of mass isotopomers. For isotopologues of peptides taken from
samples with no isotopic enrichment, isotopic clusters are observed from the naturally
occurring heavy isotopes of C, N, S, H and O. However, the number of observable
mass isotopomers for a peptide synthesized from natural substrate are significantly
less than when peptides are synthesized from enriched substrate. This places greater
demand on the instruments ability to provide accurate, precise, and isotopically precise
mass measurements. For clarity, accurate is defined as the instruments ability to
report the true mass of a molecular species while precise means the reproducibility of
mass measurements from di↵erent biological, technical or chromatographic samples.
Isotopically precise means that the mass di↵erences between each isotopomer and the
theoretical mass should be consistent. For example, if the measured m+0 isotopomer
is 5 ppm from the theoretical mass, then all other mass isotopomers should be 5 ppm
away from their theoretical masses.
The instruments most suitable for these requirements are bench-top mass spec-
trometers coupled to an Orbitrap mass analyzer (Hu et al., 2005). The Orbitrap has
been usd to identify an unprecedented number of peptides and proteins from highly
complex samples. For example, Nagaraj et al. (2012) were able to identify 4000 pro-
teins from 30,000 sequenced peptides from a single orbitrap experiment, resulting in
nearly complete coverage of the yeast proteome. Such high identification rates are
a function of the key attributes of the Orbitrap: mass accuracy, resolution and
dynamic range (Makarov et al., 2006).
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2.1.1 Mass Accuracy, Resolution and Sample Rate
Since the invention of the Orbitrap in 2005, a number of studies have verified high
mass accuracy, ranging from 2-5 ppm (Makarov et al. (2006), Perry et al. (2008)).
However, sub-ppm mass accuracy has been demonstrated when using real-time, ”lock”
mass calibration (Olsen et al., 2005). Additional computational techniques have also
increased the mass capability of the instruments, enabling measurements to reach
the ppb range by matching mass measurements from identical peptides in di↵erent
charge states (Cox and Mann, 2009).
While the linear trap quadrapole (LTQ) coupled to an Orbitrap can achieve a
resolution as high as 150,000, they are typically run between 30,000 because of slower
scanning rates, resulting in a smaller number of samples. Typically, the resolution
for an LTQ Orbitrap is set at 30,000, a mass accuracy of 5ppm is achievable with
an average sample time of 1 second (Yates et al., 2006). Newer instruments like the
Q-Exactive Orbitrap have been shown to perform better than the LTQ-Orbitrap by
simultaneously achieving faster scanning rates and mass resolution. For example, for
the ultra high resolution Orbitrap EliteTM, the spectra for a complete isotopically
resolved protein in the +47 charge state was recently demonstrated at a 2.5 second
sample time with a resolution over 100,000 (Michalski et al., 2012).
2.1.2 Dynamic Range and RIA Quantification
Compared to characterizing the mass accuracy and resolution of Orbitrap instru-
ments, the quality of RIA quantification has received little attention. In particular,
studies have not rigorously assessed the quality of RIAs from any statistical point of
view by accounting for sampling variance of isotopologue populations. Initial studies
on the dynamic range give some idea on the instruments capacity. For example, a
signal dynamic range was shown to be approximately 5000 for early Orbitrap models
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(Makarov et al., 2006).
RIA quantification errors were reported to fall within 4-5% of theoretical mea-
surements (Okawa et al., 2013). However, identified peaks were normalized prior
to error calculation, thus no consideration was made for sampling variance. Further-
more, there was no discussion on correcting for potential RIA bias. It has been shown
that isotope discrimination exists for certain enzymes, most notably being RuBisCO
(Wong and Sackett, 1975), and has recently been shown to directly e↵ect labeling
patterns (Wasylenko and Stephanopoulos, 2013). RIA accuracy was also shown to
decrease for increasing resolution, which is likely caused by decreased sampling fre-
quency (Okawa et al., 2013). However, the tradeo↵s between resolution and scan
scanning rates on the quantification of RIAs have yet to be rigorously investigated.
Recently, Kaufmann and Walker (2012) have shown that accuracy of RIA quan-
tification could be e↵ected by a number of physical and mathematical phenomena,
such as ion suppression, ion coalescence, and artifacts from the Fourier transform
(FT). Regardless, these e↵ects are less pronounced in Orbitrap mass spectrometry
relative to other forms of FT-MS due to high resolving power and large space filling
capacity of the trapping device.
Although the quantitative capacity for measuring RIAs have received little atten-
tion, the high mass accuracy, dynamic range, and protein and peptide identification
rates makes the technology suitable for the quantification of PMDs for peptide-based
metabolic flux analysis.
2.2 Isotopic Labeling for Proteomics
The use of stable isotopes in proteomics is well-established, with techniques rang-
ing from in vitro labeling of residues (ICAT), termini (18O), and functional groups
(mTRAQ) as well as metabolic, in vivo labeling using elemental isotopic enrichment
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with 15N or 13C, or incorporation of heavy variants of amino acids (e.g. SILAC)
(Becker, 2008).
Most quantitative proteomic experiments that utilize the incorporation of stable
isotopes into proteins in vivo are used for comparative or di↵erential proteomics. In
these experiments, one sample is grown with natural substrate while the other is
exposed to isotopically labeled substrate. For example, in a SILAC experiment, the
isotopically labeled substrate is typically a 13C, 15N or 18O varient of an amino acid
supplied to the cell culture media (Geiger et al., 2011). The two samples are combined
and relative protein quantities are determined by the relative abundances of light and
heavy isotopic clusters. The key di↵erence between data produced from this type
of experiment and the data produced from a metabolic labeling experiment is that
comparative proteomic experiments produce two flux-independent isotopic distribu-
tions, while peptide-based flux analysis produces one flux-dependent isotopic cluster.
Figure 2.1 illustrates the di↵erences between this type of data. In the first case, a
flux-dependent MID is observed for a 4 carbon species. As described in Section 1.5,
case (1) cannot be accurately simulated unless a flux distribution is known. However,
in case (2), both MIDs are flux independent because each isotopologue population is
uniformly labeled. In case (2), the ”labeling” illustrated is in vivo, but the principles
can be extended to in vitro labeling as well.
In most quantitative proteomics experiments, the objective is to measure the ratio
between heavy and light isotopologue populations. This is performed by taking the
ratio between either the monoisotopic peaks (i.e. m+0 peak) or the base-peaks
(i.e. most abundant peak) from each population. Extracting MIDs and accurately
quantifying all isotopomer abundances for a group of isotopologues is often not nec-
essary. Thus, software designed for quantitative proteomics to date is not su cient
for automated extraction of flux-dependent PMDs.
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Figure 2.1: Example of di↵erence between PMDs generated from a flux-dependent
labeling experiment and a comparative quantitative proteomics experiments
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2.3 Data Analysis: Approaches and Tools
Several software frameworks consisting of suites of algorithms for the analysis of mass
spectrometry been developed over the last decade in response to the development of
new mass spectrometry technology. Some software provide fully automated workflows
for the identification and quantification of peptides using established techniques, such
as MaxQuant, while others provide interfaces for the user defined workflows, such
as XCMS/mzMatch (Smith et al., 2006), OpenMS (Reinert and Kohlbacher, 2010),
Trans Proteome Pipeline (TPP) (Kohlbacher et al., 2007), and ProteoWizard (Kess-
ner et al., 2008). Although these software suites are constantly growing to accompany
current technology and techniques, established workflows for the automated extrac-
tion of non-natural peptide distributions have not been demonstrated within any of
these frameworks. Although this specific goal has not been achieved, modular algo-
rithms and paradigms for pre-processing LC-MS data have been developed in e↵ort to
allow for flexible software development for new techniques. As Listgarten and Emili
(2005) state, most low level pre-processing algorithms have been ”parenthetically per-
formed within the larger goal of sequence-based identification”, thus not rigorously
tested or developed within the proteomics community. However, significant work as
been done within the metabolomics community to identify flux-dependent isotopically
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enriched metabolites.
In this section, a brief discussion of algorithms and software available for pre-
processing LC-MS data are described, with an emphasis on the limitations of these
approaches when attempting to extract and quantify PMDs from MFA experiments.
2.3.1 LC-MS Preprocessing
LC-MS preprocessing algorithms first attempt to distinguish noise from peaks, or
pairs of m/z and intensity measurements that represent a single measurement within
an extracted ion chromatogram (EIC). EIC’s are then grouped into the full set of
isotopologue measurements for a single molecule, or features. Algorithms used for
identifying peaks and features have limited use for peptide based MFA PMDs. For
example, the first step in most algorithms is to remove low-frequency noise from data
sets by using one of many filtering approaches, including Savitzky-Golay and lowess
smoothing algorithms. However, filtering techniques often have di culty distinguish-
ing between low abundant peaks and noise.
Filtering and smoothing is typically followed by peak identification. Zhang et al.
(2009) recently reviewed approaches for LC-MS peak picking. Currently three ap-
proaches are taken to distinguish peaks from noise: (1) the shape of the extracted ion
chromatogram, (2) the isotope pattern and (3) a combination of (1) and (2). To date,
the most successful peak picking algorithms are based the isotope pattern of peptides
rather than the shape of the ion chromatogram because of the discrete, sampling na-
ture of peaks throughout time. Common isotope-matching peak picking algorithms
such as Superhirn (Mueller et al., 2007) and VIPER (Monroe et al., 2007) cannot be
used for the detection flux-dependent PMDs: the isotopic distribution is simulated
using the uniformly-labeled ”averagine model,” and fitted to the measurement.
Approaches that solely rely on the shape of the ion chromatogram are not ca-
pable of extracting low abundant peptides. Furthermore, the poor performance of
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chromatographic peak detection methods can be attributed to the assumption that
elution profiles are Gaussian shaped, which is not necessarily true and depends on
the saturation state of the stationary phase on the column (Rouessac and Rouessac,
2007). Some improvements have been developed within the metabolomics community
recently to account for this by applying a continuous wavelet transoformation in the
chromatographic domain (Tautenhahn et al., 2008), however have not been applied
to high resolution proteomic datasets.
2.3.2 Software
Most of the software development developed for the automated extraction and vi-
sualization of isotope-labeled mass spectrometry data have come from within the
metabolomics community. Currently, there are four software tools available for the ex-
traction and quantification of labeled metabolites: MAVEN, MetExtract and mzMatch-
Iso and the OpenMS tool ”FeatureFinderMetabo”. MAVEN, developed in 2010, is a
fully integrated framework for the analysis and visualization of mass spectrometry
data, which uses a neural network to detect and group peaks based on a set of met-
rics developed from manually extracted data (Melamud et al., 2010). However, the
metrics used in the algorithm are based on manually annotated peaks from small
metabolite MIDs rather than peptide MIDs.
Bueschl et al. (2012) developed MetExtract for a specific subset of isotopically
enriched LC-MS datasets, requiring the presence of isotopologues in the fully un-
labeled and full labeled states, which is not typically observed for peptide-based
MFA. Chokkathukalam et al. (2013) recently developed an R-based tool for the anno-
tation and quantification of isotope labeled mass spectrometry data, mzMatch-ISO,
however require multiple biological samples for optimal performance. OpenMS al-
gorithm ”FeatureFindeterMetabo” is a flexible algorithm that attempts to identify
metabolites with arbitrary isotopic enrichment, however was not capable of identify-
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ing isotopically enriched PMDs. After parameters had been optimized, the algorithm
annotated single PMDs as multiple molecular species resulting in subsets of identified
PMDs. For example, mass isotopomers m+0 and m+1 would be grouped as a single
peptide species, while m+2 and m+3 would be classified as another.
All four software packages are limited in scope to metabolomics experiments and
are not currently applicable for the detection of larger metabolites such as peptides.
The following chapter describes a new approach to automatically extract and quantify
PMDs that circumvents the algorithmic and software limitations of these software
packages by compressing the elution characteristics of ion chromatograms and the
mass accuracy and precision capabilities of the Orbitrap into a single data type.
Chapter 3
Methods: Software Design and
Development
In this chapter, the methods developed for the automated extraction of peptide MIDs
from labeled data sets are described. In Section 3.1, a complete workflow is provided,
as well as a description of the training data set used for method development. Sec-
tion 3.2 provides a summary for the working protocol used to identify peptide species
from unlabeled data sets, specifically focusing on additional data provided via algo-
rithms used in MaxQuant for m/z recalibration. Section 3.3 describes the working
protocol developed for the reduction of data using the open source software suite
OpenMS, including methods developed to optimize software parameters. Section 3.4
describes the development of in-house MATLAB modules that filters and groups
mass traces into peptide spectral features, including a discussion of parameter opti-
mization and tradeo↵s associated with parameter choices. Section 3.5 describes novel
algorithms developed for quantification and error estimation of peptide MIDs for high
resolution, high-throughput mass spectrometry.
28
3.1. Experimental Design 29
3.1 Experimental Design
3.1.1 Workflow
The quantification of flux-dependent isotopically enriched peptide MIDs requires an
unlabeled sample as well as the labeled sample (see Figure 3.1). Both data sets are
generated from samples subjected to identical protein preparation, LC-MS protocols
and culturing conditions, di↵ering only in isotopic enrichment of the substrate in the
culture media. The unlabeled sample is used to determine the set of proteins and
peptides one could observe under the specific culturing conditions using standard
identification software suites. The number of peptides observed within an unlabeled
sample is maximized in a two-step search protocol described in Section 3.2 using
MaxQuant/Andromeda (Cox and Mann (2008), Cox et al. (2011)). Furthermore,
each peptide is annotated with an observed m/z, corrected for instrument m/z bias or
inaccuracy. The labeled sample is processed with the open source software OpenMS to
reduce the raw data into a groups ofm/z measurements observed in time. The peptide
database and mass traces are imported into MATLAB for the identification of peptide
features using a hierarchical clustering algorithm. This is based on the construction
of a similarity matrix for groups of mass traces that integrates isotopic accuracy
information with the covariance of ion chromatograms. MIDs are then quantified
using a constrained non-linear optimization technique that finds the optimal MID
and standard errors for a peptide.
3.1.2 Training Set
In order to develop a suitable workflow for unpredictable peptide MIDs from labeling
experiments, we used a training set consisting of 17 peptides identified from labeled
and unlabeled Soybean, Glycine max cv. Jack. Embryo culture conditions, protein
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Figure 3.1: Peptide MID Quantification Workflow
preparation and LC-MS protocol are described in (Mandy et al., 2013) (submitted,
in review). All samples were run on a LTQ-Orbitrap Velos mass spectrometer in
positive ion mode within an m/z range of 50 - 2000 Da, with a resolution of 60,000
at 400 m/z and with an automatic gain control set to 1,000,000 charges. Peptides
of the proteins glycinin and conglycinin were identified from unlabeled samples using
Mascot Distiller v2.4 and searched using Mascot Daemon (Matrix science, London,
U.K.). Identification of peptides was based upon NCBI library and a trypsin cleavage
pattern, 0.80 Da and 15 ppm fragment and parent tolerances, respectively. Protein
modifications inlcuded were carbamidomethylation of cysteine, oxidation of methio-
nine and deamination of glutamine and asparagine. m/z measurements for the m+0
isotopomer were recorded and used as a reference value to search for that peptide
within labeled data. Table 3.1 contains a list of all manually identified peptides,
charge states, theoretical and reference m/z measurements, mass error, full-width at
half-height (FWHH) spanning retention times, number of mass isotopomers and the
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charge theoretical
m/z
reference
m/z
mass
error
(ppm)
FWHH(s) isotopomers sample
rate
LLK 2 187.14 187.15 6.55 19.14 10 1
DYR 2 227.11 227.11 6.61 12.12 12 0.98
VLFGR 2 296.18 296.19 2.54 9.85 12 0.97
NKNPFHFNSK 4 308.91 308.91 3.33 11.52 18 1
VLFSR 2 311.19 311.19 3.14 13.96 13 0.97
NPFHFNSK 3 330.83 330.83 2.75 9.03 13 0.97
SRDPIYSNK 3 360.52 360.52 6.18 12.48 29 0.98
NFLAGSK 2 368.70 368.70 2.52 16.41 9 0.98
FEEINK 2 390.20 390.20 3.72 7.42 24 0.96
FQTLFK 2 392.22 392.22 3.19 4.93 19 0.99
NKNPFHFNSK 3 411.54 411.55 3.39 12.34 20 0.97
DIENLIK 2 422.74 422.74 3.14 9.02 28 0.98
LQSGDALR 2 430.24 430.24 3.61 9.91 25 0.95
NKNPFLFGSNR 3 431.89 431.90 3.43 17.23 23 0.70
FEEINKVLFGR 3 451.25 451.25 3.13 7.38 36 0.98
LQESVIVEISKK 3 458.27 458.28 4.68 14.77 47 0.95
FEEINKVLFSR 3 461.25 461.26 3.46 5.74 34 0.92
Table 3.1: Training set
sample rate for all expected measurements.
The remaining sections of the chapter aim to comprehensively describe the meth-
ods and development of the automated workflow via discussion of three key parts:
• Description of the procedure from a pragmatic and algorithmic motivation
• Discuss key parameters required each method or algorithm
• Discuss characteristics from the training set used to develop the method
3.2 Peptide Identification
The workflow requires an unlabeled sample to first identify peptides sequences and
charge states. A targeted search is performed using these peptides species to find
peptides within labeled samples based on observed m/z measurements. An un-
targeted search would use either MS2 data from labeled samples, or attempt to
identify peptides solely based on m/z. Currently, there are no proven software solu-
tions for un-targeted identification of isotopically enriched peptides. The XCMS ex-
tension, mzMatch-ISO is currently the only software package capable of un-targeted
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identification of labeled metabolites. However, we were unable to accurately identify
and quantify any of the peptides within the training set when using mzMatch-ISO.
Procedure
The computational proteomics software suite, MaxQuant v 1.3.0.5 ( Max Planck In-
stitute of Biochemistry, Martinsried, Germany) was used to identify peptides within
an unlabeled sample. The unlabeled sample was first loaded into the MaxQuant GUI
hosted by the Minnesota Supercomputing Institute (MSI). The reference proteome for
Glycine hispidia was used for all searches and was obtained from UniProt (UniProt
Consortium). The database was loaded into Andromeda and configured according
to the supplied protocol. Within the group specific parameters, the variable mod-
ifications included were carbamidomethylation of cysteine, oxidation of methionine
and deamination of glutamine and asparagine. The digestion enzyme trypsin was
specified with a multiplicity of 1, and a mass accuracy for the first and second pep-
tide searches was set to 20 and 6ppm, respectively. A maximum of 5 modifications
per peptide were allowed, and peptides contained a maximum of 4 missed cleavage
sites. Peptides were allowed to carry +1 to +7 charge units. MS/MS fragmentation
parameters were left to default, while identification and quantification parameters
were set manually. The minimum length of a peptide used for identification was 3
amino acids. Peptide and protein false discovery rates were set to 0.01. One pos-
itively identified peptide was required for the protein identification. However, this
peptide was not required to be unique. This was done to ensure maximal coverage
and identification for m/z recalibration. All other parameters were set to default.
MaxQuant produces a directory containing multiple output files. The directory con-
tains information integrated by the MaxQuant parser MATLAB module to create a
protein data structure described in Appendix A. The protein data-structure was then
used to generate a new FASTA file, but only with the subset of proteins previously
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identified. The MaxQuant identification protocol is then performed using the new
FASTA database, resulting in a new protein data structure with a higher number of
unique peptides per identified protein. This new protein data structure is used as an
input into the feature identification MATLAB module described in Section 3.4.
MaxQuant identifies more peptides than Sequest or Mascot
Peptide identification rates using MaxQuant, Sequest and Mascot were compared by
identifying peptides from the unlabeled soy sample. All parameter choices for Sequest
were identical to those used for MaxQuant searches. MaxQuant outperformed both
Sequest and Mascot by identifiying significantly more peptides within the sample;
the number of peptides identified increased by 75% when using MaxQuant compared
to Sequest (MaxQuant/Andromeda: 230, Sequest: 131, Mascot: 29). Furthermore,
the probability associated with the identification of peptides did not su↵er: the mean
posterior error probability (PEP) for the 230 peptides was 0.0113±0.0174, indicating
that 99% of the measurements have atleast a 95% probability of being correctly being
annotated, compared to 131 for Sequest.
Two-step search results in a larger number of unique peptides
Using the full UniProt FASTA file, 154 peptides were identified using MaxQuant while
after the FASTA file was reduced 230 peptides were identified. To analyze the quality
of identifications, we looked at how the PEP for peptides identified in both the first
and second stages changed by taking the ratio of the PEP of the first identification
and the second. We identified 151 peptides identified in both stages and observed an
average decrease in PEP by three orders of magnitude, indicating that by limiting
the possible set of peptides in our search database, the probability that the identified
peptide was correctly annotated increases.
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Potential uses for m/z recalibration data
MaxQuant was chosen because of its ability to rescale the m/z domain by using
identified charge state pairs within a sample. Precursor ions in the MS1 spectra
are first matched to sequenced peptides from MS2 data. MS1 spectra for peptides
from di↵erent charge states are then used to rescale the raw, MS1 spectra. The
identification algorithm provides adjusted scores for identfieid peptides based on the
rescaled MS1 spectra.
If m/z deviation is a machine-dependent phenomena, we would expect that m/z
calibration could be described as a function of the m/z measurement. The calibration
function could then be used to transform labeled datasets into datasets with more
accurate masses. To investigate this, we looked at the di↵erence between uncalibrated
m/z measurements and calibrated m/z measurements in both the time-invariant m/z
domain and the m/z -invariant time domain, respectively. MaxQuant was able to
match 692 MS2 spectra to a set of redundant peptide species, with 434 being used
for m/z recalibration. Figure 3.2 shows the relationship between uncalibrated m/z
measurements and calibrated m/z measures as a function of m/z (left panel) and as
a function of retention time (right panel). The figure indicates that m/z calibration
is primarily a function of mass drift in time rather than mass bias within the m/z
domain.
Currently, we do not attempt to use this information to transform data from la-
beled samples because the m/z recalibration function is sample dependent, rather
than simply instrument dependent. If error associated with m/z measurements were
sample independent, then the non-linear m/z recalibration function would be similar
for multiple samples. Figure 3.2 shows m/z calibration data for two separate unla-
beled samples run on the same instrument. This shows that the relationship between
m/z or retention time and m/z calibration is not necessarily reproducible. Therefore,
currently the main advantage of using MaxQuant is identification of more peptides
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Figure 3.2: Comparing m/z recalibration for multiple samples
in the unlabeled sample.
3.3 Reduction of Labeled Data to Mass Traces
In this section, the reduction of raw data from labeled samples into mass traces is
described using a workflow developed with The OpenMS Proteomic Pipeline (TOPP).
The section first focuses on the workflow implemented followed by a discussion of key
parameters within the workflow. The optimization of parameters based on the train-
ing set is then used to develop a scheme to determine optimal mass trace extraction
parameters.
A mass trace is defined as a set of similar m/z measurements observed within
spanning retention time at high frequency. The isotopologue abundance as a function
of time for a mass trace is equivalent to an extracted ion chromatogram (EIC) if the
mass trace contains all m/z measurements associated with an ion species. However,
it is often the case that the true EIC is made up of several mass traces. It is the goal
of this work to find the parameter set that maximizes the likelihood a mass trace
contains all measurements within an ion chromatogram spanning FWHH retention
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time.
Method
The raw data in mzXML format was then loaded into the TOPPAS environment and
converted to mzML format. Peak reduction was performed using a S/N cuto↵ of 1,
using the ”PeakPickerHiRes” algorithm. The peaks were then reduced to mass traces
using the ”Mass Trace Extractor” algorithm. Table 3.2 lists the optimized values,
default values and descriptions of all parameters used with the OpenMS mass trace
extraction tool.
Parameter optimization
Parameter values were adjusted to maximize the similarity between any pair of mass
traces within an isotopic cluster. For a set of mass traces within an isotopic cluster,
the similarity can by captured by determining the degree of overlap of mass trace
measurements in time. We can use the Jaccard similarity statistic, J(A,B), to de-
termine the degree of measurement overlap between mass trace A and mass trace B
such that
J(A,B) =
|A \ B|
|A [ B| (3.1)
where A and B are scan sets for mass trace A and B, respectively. Within the context
of LCMS data, the jaccard similarity statistic measures the number of shared scans
between two mass traces as a fraction of number of total scan events for both mass
traces. If scan event sets for mass trace A and mass trace B were equal, then their
jaccard similarity would be 1. If scan event sets for mass trace A and mass trace B
were disjoint, then their jaccard similarity would be 0.
The jaccard similarity index for scan sets captures multiple characteristics of mass
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Parameter Current(Default) Description
noise threshold 500(10) Intensity threshold below which
peaks are regarded as noise
chromatogram peak S/N 1(3) Minimum S/N ratio a mass trace
should have
chromatogram FWHM 10(5) Expected chromatographic peak
width (seconds)
mass error (ppm) 4(20) Allowed mass deviation
reestimate mass trace SD true(true) Enables dynamic re-estimation of
m/z variance during mass trace
collection
minimum sample rate 0.5(0.5) Minimum fraction of scans along
the mass trace that must contain
a peak
minimum trace length 0.8(5) Minimum expected length of
mass trace (in seconds)
width filtering o↵(o↵) Enable filtering of unlikely peak
widths
min FWHH 0.15(3) Minimum full-width-at-half-
maximum of chromatographic
peaks
max FWHH 65(60) Maximum full-width-at-half-
maximum of chromatographic
peaks
S/N filtering false (false) Apply post-filtering by signal-to-
noise ratio after smoothing
maximum trace length 850 (300) Maximum length of a mass trace
(in seconds)
enabled false(true) Enables/disables the chromato-
graphic peak detection of mass
traces
Table 3.2: Mass trace extraction parameter list
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traces, including the tradeo↵s between sample-rate and mass consistency. For exam-
ple, if the sample-rate or the mass consistency parameter is too large, two distinct ion
chromatograms with similar m/z values can be artificially connected into one mass
trace. If we were to compare the scan event sets for this combined mass trace with
a true mass trace from another isotopomer, we would see a decrease in similarity.
Additionally, if the sample rate is too low then real mass traces will be truncated
into multiple mass traces. If the mass consistency constraint is too low, gaps will be
introduced within mass traces, which reduces the sample rate.
To explore these trade-o↵s, we built mass traces from extracted ion chromatograms
at FWHH for all peptides in the training set at di↵erent mass consistency cuto↵s.
First, the S/N-weighted mean for each mass trace was calculated using measurements
within FWHH. Measurements that fell within the mass consistency cuto↵ for each
scan event were identified. Scan events that had a measurement were then grouped
into sets based on a specified maximal gap-size, which indirectly represents the sample
rate parameter. All scan event sets that contained the scan events at FWHH were
then assigned as the true mass trace scan set.
The jaccard similarity statistic was then calculated for each mass trace combi-
nation within a peptide. The collection of jaccard statistics were summed over all
combinations, and subsequently summed for all peptides. This produced one summed
jaccard statistic, which was plotted for di↵erent mass consistency and gap-size cut-
o↵s in Figure 3.3. It was observed that the maximum similarity between mass traces
within the training set with a 4 ppm mass consistency parameter a gap-size of 0.
However, at this mass consistency parameter cuto↵ and gap-size, 13% of the mass
traces were not identified in our sample (47/372). This was because these mass traces
contained very few measurements. Therefore, increasing the sample rate paramater
results in more mass traces extracted, albeit at the expense of isotopic cluster simi-
larity. We chose to use a sample-rate cuto↵ of 0.5 to ensure the collection of sparse
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Figure 3.3: Relationship between m/z consistency and sample rate: Panel A: mass
consistency cuto↵ vs summed jaccard similarity. Each line represents a set of mass
traces constructed using a di↵erent maximum gapsize cuto↵. Panel B: two con-
structed mass traces for NKNPFHFNSK using an m/z consistency cuto↵ and gapsize
cuto↵ of (B1) 4 ppm and 0 and (B2) 4 ppm and 2, respectively
mass traces while retaining a significantly high similarity.
The remaining parameters were directly calculated using the mass traces generated
using the optimal mass consistency parameter and sample gap-size. 372 mass traces
were extracted, resulting in a total of 34,564 individual measurements. The range of
mass trace lengths were 0.82 - 838.19 seconds, with a mean of 77.65 and median of
27.54 s. The minimum intensity value was 524, and the minimum S/N ratio was 1.06.
For 22 of the 372 extracted mass traces, we coud not calculate FWHH ion chro-
matogram estimates because measurement observance was either too sparse in fre-
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Figure 3.4: Relationship between m/z retention time length and ion abundance
quency or too low in abundance. Of the 350 mass traces, a mean FWHH of 9.70(SD:
9.21s) was observed with a full range of 0.15  63.5s.
Lastly, it was observed that there is a strong relationship between mass trace
retention time length and ion abundance (see Figure 3.4). The large range of full
peak widths and peak widths at FWHH reflect the large range in abundance for
each isotopomer. For example, in Figure 3.4 the largest mass trace is over 5 orders
of magnitude larger than the smallest mass trace. To ensure the inclusion of mass
traces with low abundance, we chose to disable peak width filtering within mass trace
extraction. Limited peak-shape information is available in low abundant mass traces
because the isotopologue abundance is dominated by sampling probability. Thus,
it is di cult to include such contraints in the mass extraction algorithm without
incorporating probabilistic information.
3.4 Feature Identification
Once mass traces were properly constructed and peptide information was obtained
from MaxQuant, mass traces needed to be assigned to their appropriate mass iso-
topomer within an isotopic cluster. The collection of mass traces that belong to
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one molecular species is defined as a feature. This section describes the algorithm
developed for identification of features for isotopically enriched peptides. Unlike algo-
rithms described in Section 2.3.1, our method requires minimal information of isotopic
distributions.
Depending on the conditions of the labeling experiment, mass isotopomers typi-
cally observed under natural conditions might fall below the limit of detection. This
might result in discontinuous mass states or light mass states that are not observable.
Therefore, it was our goal to design an algorithm that is flexible enough to identify
peptide features consisting of random MIDs. The workflow and algorithms described
in this section are encapsulated in the feature identification MATLAB module. Sec-
tion 3.4.1 describes the reduction of potential mass traces that could belong to a
particular peptide species using reference m/z and retention time values, while Sec-
tion 3.4.2 describes the algorithm designed to group mass traces into peptide features.
3.4.1 Filtering Raw Data
Before mass traces were clustered for a particular peptide species, the full mass trace
set was reduced to a set of mass traces that fell within a mass accuracy cuto↵
(MAC) and a retention time window cuto↵ (RTW). For a given peptide species,
m/z values were simulated for all possible 13C mass isotopomers using the reference
m/z provided by MaxQuant. Mass traces previously characterized were used to cal-
culate an appropriate MAC paramater and RTW parameter. The mass accuracy
parameter was determined by comparing the S/N-weighted average m/z for a mass
trace to the simulated m/z. For the 325 mass traces previously discussed, a mass
di↵erence of as much as 60 ppm was observed. However, the majority of mass traces
fell below 12 ppm. The maximum di↵erence between observed retention time in the
unlabeled sample and retention time in the labeled sample was 1.75 minutes. Default
values for the filtering algorithm is currently set at MAC of 20 ppm and RTW of ±2
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minutes.
3.4.2 Clustering Mass Traces
Mass traces were clustered based on the assumptions that mass traces belonging to
the same isotopic cluster should contain a degree of similarity in time and mass. This
section describes the procedure developed to integrate both types of data to form
similarity vectors for each mass trace.
Signal Information
A signal matrix, X, was constructed for the set of filtered mass traces,M consisting
of M mass traces. Suppose that Si represents the scan event set for the ith filtered
mass trace in M,
{si,1, . . . , si,j, . . . , si,Ni} 2 Si
The union of all scan event sets were then taken, such that St = S1[ · · ·[SM . Thus,
St contains all scan events observed within the collection of mass traces, where
{s1, . . . , si,k, . . . , si,N} 2 St
with N representing the total number of scans observed in St.
The S/N ratio xi,k was the calculated for each mass trace i and scan event si,j.
An M by N matrix, X, was constructed with elements xi,k. Note that if mass trace i
contained no observable signal at scan event k, xi,k was set to zero. Rows and columns
in X represent mass traces and independent scan events, respectively.
The sample covariance matrix, C = Cov (XT ), was calculated to exploit the ob-
servation that mass traces that belong within the same isotopic cluster share similar
elution profiles. In other words, peaks drawn from the same isotopologue population
should have peak shapes that correlate with one another in time. This is expected
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when the RIA for any mass trace is independent of when it comes o↵ the chromatog-
raphy column (see Appendix D). C contains elements ci,j that reflect the covariance
between mass trace i and mass trace j. The covariance was then transformed into the
correlation matrix, R, by element-wise division by the dyadic of mass trace standard
deviations.
m/z Information
A m/z weighting matrix, W (with elements wi,j), was constructed to capture the
isotopic precision between mass traces that belong within the same isotopic cluster.
Although the mass accuracy of a single ion species measured in di↵erent samples can
vary up to 60 ppm, the di↵erence between measured m/z values and theoretical m/z
values of ions coming from the same group of isotopologues should be consistent. This
is because for all pairs of adjacent 13C isotopomers (e.g. m+0 and m+1), their mass is
distinctly separated by 1.003355 amu. Thus, we can simulate theoretical m/z values
for all mass isotopomers based on a reference m/z from any isotopomer observed in
a separate sample, and subsequently measure the di↵erence from the observed mass
trace to the closest simulated m/z value.
First, the S/N-weighted m/z value for each mass trace was calculated for each
mass trace. For each m/z value, mi, the isotopic accuracy, di, was calculated by
taking the signed di↵erence from the closest simulated isotopomer, mk,sim such that
di =
mi  mk,sim
mk,sim
⇥ 106
The isotopic precision,  i,j, between mass trace i and j was calculated by taking
the absolute di↵erence between respective isotopic accuracies, where  i,j = |di   dj|.
The isotopic precision was then mapped to values between 0 and 1, using the following
gaussian transformation:
wi,j = e
 ( i,j)2
2 2 (3.2)
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Figure 3.5: Comparison between di↵erent similarity matricies: A) S/N correlation
matrix, B) m/z weighting matrix and C) similarity matrix
where   is a function of the di↵erence in ppm one would expect at half similarity,
such that   =  i,j,1/2/
p
2ln2. This functional mapping is called isotopic similarity.
Thus,  i,j,1/2 can be parameterized based on observed isotopic similarity between mass
traces belonging to the same peptide.
Similarity Matrix Construction
A similarity matrix, Q, was constructed to integrate both the signal information and
m/z information into a single rank-deficient matrix to be used for clustering. The
goal of this transformation was to preserve both both high positive and negative
correlation between mass traces while reducing correlation between mass traces with
high signal correlation, but low isotopic similarity. This was achieved by constructing
elements of Q, qi,j, using the following formula:
qi,j =
8<: ri,j ri,j  0ri,j ⇥ wi,j ri,j > 0
By requiring that the correlation is positive when multiplied by the weighting factor,
we ensure that negative correlations between mass traces with low isotopic similarity
are not lost. Figure 3.5 compares R, W and Q. Rows of Q are defined as similarity
vectors for each mass trace.
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Mass Trace Clustering
To group mass traces with high similarity, an allogomerative hierarchal clustering
algorithm was developed. Similarity vectors were clustered using Ward’s minimum
variance method with a Euclidean distance metric. This was the appropriate method
and distance metric for cluster analysis because vectors associated with mass traces
that belong within the same isotopic cluster should have minimal variance. At each
stage in the method, a mass trace is selected from the remaining set of mass traces
such that the inter-cluster variance between information vectors is minimal. This
ensures that each mass trace appended to the growing cluster belongs within the
cluster more than the remaining mass traces.
The Linkage utility in MATLAB was used to perform clustering on the similarity
matrix, which produces a matrix encoding the information needed to construct the
dendrogram. An algorithm was developed to identify each node in the dendrogram as
a potential feature. Features were built from the bottom of the dendrogram by first
identifying the node with least variance. Parent nodes were identified as potential
features iteratively until a group contained two of the same type mass isotopomer. For
example, if a child node contained potential m+0 and m+1 mass isotopomers and its
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parent node contained another potential m+0, then the child node would be a feature.
The feature is removed from the dendrogram and the algorithm is repeated on the
remaining node set. This was performed until the dendrogram had been completely
segregated into features. Figure 3.8 shows an example of an identified feature that
represents VLFSR in the training set. Note that mass isotopomers are represented
exactly once per feature and multiple features can be extracted from M. The mass
trace set that corresponds to a true feature is denoted F .
There are scenarios when the inclusion of isotopomers of the same type is not a
su cient stopping criteria for feature identification. For example, suppose M con-
sisted of three mass traces, two of which are highly correlated and are potential m+0
and m+1 isotopomers, and a third less correlated mass trace that is potentially an
m+100 isotopomer. The m+0 and m+1 mass traces would be grouped first, followed
by the m+100. However, it is unlikely that these mass isotopomers belong to the
same peptide because of the large number of non-observed mass isotopomers within
the feature. To address this issue, another parameter wused as a stopping criteria
for the algorithm is the dendrogram height, H, which is a function of the variance
within a mass trace cluster. To determine how this information could be used as
stopping criteria, the relationship between the clustering of mass traces within a true
feature and the dendrogram height was established and is shown in Figure 3.7.
First, true mass traces that belonged to the feature were identified and tracked
through the clustering algorithm, where the x-axis in Figure 3.7 represents the algo-
rithm stage. Clustering began on the node containing the two most correlated mass
traces. In subsequent stages of the algorithm, the cluster node was assigned to the
parent node for the previous cluster. This was performed until there existed no other
parent nodes. At each stage in the algorithm, three metrics were calculated: 1) the
absolute dendrogram height (green line; right axis), 2) the percent of true mass traces
within the cluster (blue line; left axis) and 3) the percent of unique isotopomers within
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the cluster (red line; left axis).
It can be seen that in all cases, the stage of the algorithm that results in the
incorporation of isotopomers of the same type (represented by a drop in the red line)
results in a sharp increase in H, indicating that the change in dendrogram height, or
 H, at each stage in the algorithm might serve as a su cient additional cuto↵. The
optimal  H could be inferred visually from Figure 3.7 by finding a maximum  H
that occurs prior the incorporation of all true isotopes (represented as the sharpest
increase in the green line prior to the blue line reaching 100%), which was roughly
2.5.
After candidate features are identified using this algorithm, we can impose ad-
ditional constraints on candidate features based on observations from the training
set. For example, it is rare that there is a high degree of isotopomer discontinu-
ity within a feature. Therefore, the software segregates identified features based on
a maximum isotopomer discontinuity prior to annotation. As default, the software
requires a feature to consist of contiguous isotopomer species.
Feature Annotation
After the feature finding algorithm segregates the hierarchical cluster into potential
features, the feature that most likely belongs to the molecule of interest needs to be
identified. Currently, more information is required to determine which feature likely
belongs to the peptide of interest, thus the software requires that a unique feature be
identified per peptide.
In order to maximize recovery, two approaches were developed: the first allows
incorporation of a parameter associated with the probability of observing a user-
defined mass isotopomer, while the second calculates an expected isotopomer from
the initial set of identified features. While the first approach relies on prior knowledge
of the experiment, the second is an unsupervised approach to characterize isotopic
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Figure 3.7: Analysis of potential stopping criteria for feature identification algorithm:
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distributions within the sample.
In most experiments, a simple rule is su cient for distinguishing the correct
feature from other candidate features. For example, in most labeling experiments
there exists a population of isotopologues generated from unlabeled substrate prior
to growth with labeled media. This means there will be a significant number of iso-
topologues in lower mass states. We would then require that features must include
low mass isotopomers, such as a m+0 or m+1. If prior knowledge is known for which
isotopomers should be above the limit of detection, then a score can be assigned to
clusters based on the isotopomer index, ◆i, for the ith mass trace in the feature set F .
A probability-weighting function, w(◆i) can be generated based on the experimental
design and an annotation score can formulated, such that
Zannotation =
X
i2F
w(◆i)
Careful experimental design aimed at maximizing the annotation score of true features
is discussed in Chapter 5.
In the second approach, calculated RIAs for peptides with unique features are
used to calculate an the average 13C enrichment for the kth peptide, defined as the
average carbon label, lk. The sample mean for all lk is used to simulate MIDs
for all peptides in the original database assuming uniformly labeled substrate. The
maximum peak is determined and serves as an estimate for the base peak for that
peptide. Candidate features are then re-filtered prior to annotation by removing all
candidate features that do not include the base peak estimate. The power of this
approach is demonstrated in Section 4.2 and Section 4.3.
Feature Reduction
After the feature has been annotated, the FWHH spanning retention time is calcu-
lated by summing all mass trace signals observed per scan event to generate a total
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Figure 3.8: Feature Identification from Cluster Analysis
ion chromatogram (TIC). The maximum of the TIC is determined, and the scan event
set spanning FWHH, S, is calculated. The feature is then reduced into a feature
matrix, F , consisting of elements fi,j which are are the number of isotopologues for
mass trace i 2 F and the jth scan event in S, using the following forumula:
fi,j =
Si,j
Ni,j
K
q
R
R0
zi
(3.3)
where Si,jNi,j is the signal-to-noise ratio, zi is the charge state, R is the resolution setting
and K and R0 are instrument-specific parameters. Figure 3.9 provides an example of
a feature matrix for the peptide NKNPFLFGSNR from the training set.
3.5 Feature Quantification
Once the feature matrix is determined, individual measurements are refiltered based
on their isotopic accuracy. This is performed because of the variety of conditions that
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could account for inaccuracies in m/z measurements, most importantly the presence
of isobaric ions that cause shifts in the m/z domain (Kaufmann and Walker, 2012).
Whatever the reason for m/z inaccuracy, requiring high isotopic precision minimizes
the possibility that a contaminated peak bias the quantification of the MID. Figure 3.9
provides an example of a feature matrix after m/z measurements are filtered. In this
figure, the grid is a 4 dimensional representation of the feature, where each rectangle in
the grid represents a measurement for each mass isotopomer (y-axis) within a specific
scan event (x-axis). Filled rectangles represent peaks observed at that particular
mass and scan event combination, while empty rectangles indicate no peaks were
observed. The size and color density of each rectangle correspond to the number of
isotopologues and isotopic accuracy, respectively.
For this feature, 213 measurements were observed out of 299 expected measure-
ments (71%) using an isotopic accuracy cuto↵ of 5 ppm. However, there does not
exist a scan event that contains all observable mass isotopomers. This is problematic
because it means the MID will be calculated from a set of incomplete sampling events.
Instead of throwing away scan events that do not contain all expected isotopomers,
we chose to use a fitting approach with constrained nonlinear optimization MATLAB
utility fmincon. The advantage of this method is that makes use of all measurements
in the data set and can potentially resolve the relative abundances for isotopomers
rarely observed.
3.5.1 Estimating MIDs From Experimental Data
In order to find the most representative MIDs, we fitted relative isotopic abundances
for each observed isotopomer, pi and the total number of ions samples in scan event
sj, ⌘j to observed ion count estimates, fi,j. In the procedure, variables pi and ⌘j
were used simulate measured ion counts from each scan event. The fitting algorithm
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Figure 3.9: Example peptide from training set:
developed was:
minimize
P
i2F
P
j2S
Li,j|pi⌘j   fi,j| subject toP
i2F
pi = 1
⌘j  
P
i2F
fi,j 8j
(3.4)
where
Li,j =
8<: 0 if fi,j is 01 otherwise
Li,j was simply used as to eliminate the contribution of non-observed mass iso-
topomers to the residuum. The objective function was chosen to be of the `1-norm
type because we wanted all residuals to contribute equally to the residuum. While the
first contraint is a result of (B.1), the second constraint requires that the predicted
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sample size per scan, ⌘j, be bounded below by the observed sample size. The fitting
provided optimized mass isotope distribution probability estimates, p⇤i , and sample
sizes per scan event, ⌘⇤j . From these two optimized parameters, we can calculate
expected values at each scan event such that
E(Xi,j) = ⌘
⇤
jp
⇤
i (3.5)
3.5.2 Estimation of Experimental Error
In addition to finding optimal RIAs to construct the MID, error estimates for RIAs
were determined. If peptide MIDs are to be used for metabolic flux analysis (or any
technique requiring fitting a set of parameters to MIDs), then error estimates are
required for the calculation of parameter confidence intervals. This sections describes
the methods developed to estimate errors for RIAs using a multinomial sampling
model.
Each scan is a discrete sampling event of the total isotopologue population, where
the sample size is directly related to the set of isotopologues eluting o↵ the liquid
chromatography column at that specific retention time. Although there was no ev-
idence for systematic bias for later scan events enriched with heavy isotopes (see
Appendix D), the absence of measurements described in Section 3.5 as well as intrin-
sic sampling variance described in Appendix B provided reason for developing a more
sophisticated approach to estimate the error for each RIA.
We determined an estimate of variance for a particular isotopomer by fitting the
multinomial standard deviation to an estimation of measured standard deviation
using a multinomial sampling model. It was hypothesized that the relative frequency
of each isotopomer from scan to scan varies as a function of multinomial sampling
variance, m/z inaccuracy, and unknown experimental variance. The goal was to
derive a relationship between the multinomial variance and the measured variance,
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where we could use the theoretical error to predict experimental variance.
The sampling variance was first determined using the following equation:
Var (Xi) =
X
j2S
Li,j(fi,j   E(Xi,j))2 =
X
j2S
Li,j(fi,j   ⌘⇤jp⇤i )2 (3.6)
From the experimentally determined variance, we then calculated the sample stan-
dard deviation s(Xi) =
p
Var (Xi). Because the sampling variance was calculated
using events were no observations occurred, we investigated whether we could use
the calculated multinomial sampling variance as a predictor for measured variance.
Multinomial sampling variance, mnVar(Xi) was calculated using the fitted RIA and
sample size, such that
mnVar(Xi) =
 X
j2S
⌘⇤j
!
p⇤i (1  p⇤i ) (3.7)
where the multinomial standard deviation, mnSD(Xi,j) was calculated from multino-
mial standard deviation, such that
mnSD(Xi) =
p
mnVar(Xi)
For each peptide isotopomer in the training set, s(Xi) and mnSD(Xi) were calcu-
lated and plotted in Figure 3.10. The figures shows a linear relationship between
the standard deviation, with 91% of the variance in s(Xi) explained by mnSD(Xi).
Furthermore, the slope slightly greater than one indicates that observed variance is
dominated by sampling variance rather than instrument noise. To calculate standard
deviation estimate for a given measurement, we multiplied the calculated multinomial
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Figure 3.10: Using multinomial variance to predicted measurement variance
standard deviation by the slope of the regression plotted in Figure 3.10,  , such that:
s(Xi)estimate =  mnSD(Xi) =  
vuut X
j2S
⌘⇤j
!
p⇤i (1  p⇤i ) (3.8)
where the estimated measurement variance would be:
Var (Xi)estimate =  
2mnVar(Xi) =  
2
 X
j2S
⌘⇤j
!
p⇤i (1  p⇤i ) (3.9)
Chapter 4
Software Validation and
Implementation
In this chapter, validation experiments performed using datasets from di↵erent la-
beling experiments are discussed with an emphasis on the numerical and visual val-
idation of the of the software. For each validation data set, parameter specifications
to increase peptide recovery rates are discussed. Quantitative methods described in
Section 3.5 are used to extract relative isotope abundances (RIA) for peptides and
compared to simulated RIAs.
4.1 Unlabeled E. coli
Feature extraction and MID quantification was carried out using methods described in
Chapter 3 for E. coli grown in glucose minimal media with no isotopic enrichment. E.
coli strain G1655CGSC was cultured, protein preparation and MS data were collected
according to Allen et al. (2013). Cells were grown with M9 media with 0.4% unlabeled
glucose, total cellular protein was extracted and separated using SDS-Page. A protein
band was extracted at 43KD and an in-gel digestion was performed; samples were
reduced, alkylated and digested with trypsin. Orbitrap mass spectra were obtained
and peptides were identified according to the procedure and parameter set listed in
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Section 3.2. 37 proteins were identified in the sample with 10 or more peptides. Mass
traces were constructed using the protocol discussed in Section 3.3 and clustered
according to Section 3.4.2.
4.1.1 Analysis of Feature Identification and Extraction
To determine if the output of MaxQuant provided correct isotope assignments for
precursor ions, the isotope index for the precursor ion was determined. m/z values
were simulated for all 13C isotopomers based on the modified sequence provided by
MaxQuant. The precursor m/z value was mapped to the closest simulated m/z
value, subsequently providing a matching isotope index. The matched isotope index
was then compared to the isotope index provided by MaxQuant. Surprisingly, only
54% (349/648) of the peptides were assigned as the correct isotope. However, two
distinct cases were observed for peptides assigned the incorrect isotope index: (1)
observed monoisotopic masses provided by MaxQuant and masses calculated in-house
were nearly identical, however the peptide had been assigned as an m+1 isotopomer
instead of the correct m+0 isotopomer and (2) the masses provided by MaxQuant
were roughly 57-58 amu higher than masses calculated in-house. Although there
was no clear explanation for (1), the discrepancy in (2) was likely caused by an
unrecognized carboxymethyl modification. This hyphothesis was corroborated with
the observation that each peptide in case 2 contained atleast one cysteine. Roughly
2/3 of the isotopomer miss-assignment was explained by case (1) while approximately
1/3 was explained by case (2), indicating that 10% of peptide sequences identified by
MaxQuant contain unrecognized modifications. Once precursor ions were assigned
to their correct isotope index, peptides with undetected modifications were removed
from the validation database.
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Data Reduction
Once precursor ions were assigned to their correct isotope index, peptides with unde-
tected modifications were removed from the database resulting in a set of 558 peptides
for the 37 proteins originally identified. The protocol described in Section 3.3 was
used to generate mass traces for the same unlabeled sample used for identification.
Mass traces containing the precursor ion for each peptide were then identified. All
precursor ions existed within a mass trace when using optimized parameters described
in Section 3.3.
Feature Finding
Features were determined using the protocol described in Section 3.4.2. Mass traces
were filtered by mass and retention time, and clustered using an isotopic precision of 4
ppm and a dendrogram height of 1.5. 10 potential features were identified on average
per peptide. To assess the di↵erence between feature clusters containing the true pep-
tide and other features, we identified clusters that contained the precursor ion mass
trace. Approximately 30% (168/558) of identified features containing the precursor
ion mass trace consisted of a set of discontinuous isotopomers, with 15% (89/558)
containing isotopomer gaps of at-least 15. If a quality score based on isotopomer con-
tinuity were employed, we would potentially lose up to 30% of the peptide features.
Thus, clustered features were broken up prior to feature identification to prevent the
existence of high isotopoic discontinuity as explained in Section 3.4.2. If no gaps were
allowed, a small percentage (5%) of peptide feature sets contained only the precursor
ion mass trace. Thus, RIAs were not calculated for theses ”orphaned” features and
removed from the peptide set for further analysis. Features were refiltered with a
mass accuracy cuto↵ of 2 ppm and feature matrices were extracted for each peptide.
Peptide MIDs were calculated using the procedure described in Section 3.5.
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A small percentage of peptide features (13/558) contained a significant peak at the
m 1 position, which suggests the peptide MID is contaminated with of another molec-
ular species at that specific m/z and retention time. These peptides were removed,
leaving 484 peptides that were used for validation of the quantification software.
4.1.2 Analysis of Quantification
Unlabeled peptide MIDs from E. coli were quantified in e↵ort to validate the quan-
tification module as well as determine the quantitative characteristics of Orbitrap
data. Under natural conditions, it is assumed that the mean 13C isotopic enrich-
ment is 1.078%. However, it has been shown that isotope bias can occur in enzymes
within central carbon metabolism, most notibly RuBisCO (Wong and Sackett, 1975).
Therefore, we first attempted to calculate the mean 13C isotopic enrichment given
the measured distributions. First, the isotopic enrichments from non-carbon ele-
ments were removed from the measured distributions using deconvolution, resulting
in carbon-only MIDs, xcarbon with elements xi,carbon representing the RIA of carbon
mass isotopomer ◆i. The average carbon label, lk, per peptide k was calculated
using the following formula:
lk =
P
i2F ◆i,k ⇥ xk,i,carbon
Ck
(4.1)
where Ck are the total number of carbons in the peptide k. The weighted mean
of lk for all peptides was determined by weighing each peptide by the total number
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of observed ions, such that:
l¯ =
⇣P
j2Sk ⌘
⇤
j,k
⌘
lkP
k2P,j2Sk ⌘
⇤
j,k
(4.2)
and l¯ was compared to the theoretical 13C enrichment of 1.078%. We found
that the mean of the average carbon label for all identified peptides(n = 484) was
1.03 ± 0.09%, which was significantly smaller than the expected value of 1.078%
(p < 5%). The average carbon label deviation could be explained by an isotopomer
bias at low mass states, which was further investigated by comparing measured RIAs
to simulated RIAs for each observed isotopomer. The theoretical RIA was simulated
by first generating a carbon-only MID using the measured fractional enrichment for
13C. The carbon-only MID was then convolved with naturally occurring elemental
mass distributions for each remaining element within the peptide. The simulated
MID and the measured MID were both renormalized to eliminate the e↵ects of missing
isotopomer values. This was required because isotopomers that were not observed
have to be removed from the simulated MID, resulting in simulated distributions
that no longer sum to 1. After normalization, a nearly one-to-one relationship was
observed between simulated RIA and measured RIA (see Figure 4.1, panel (A)). A
chi-squared statistic was calculated to test the goodness of fit between the measured
RIA and the theoretical RIA. For each isotopomer, ◆i of peptide k, the measured RIA,
p⇤i,k, and the theoretical RIA, pi,k,pred were used to generate a reduced chi-squared test
statistic,  2red, for a total number of data points M and parameters ⇢, such that
 2red =
1
⌫
X
i,k
N2k (p
⇤
i,k   pi,k,pred)2
Var (pi,k,pred)estimate
(4.3)
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where Nk =
P
j2Sk ⌘
⇤
j,k and ⌫ =M ⇢ 1. The parameter set for this model is simply
the average carbon label use to generate our estimated RIAs, meaning that ⇢ = 1
(Taylor, 1996). Equation (4.3) can be reduced using equation (3.8) to the following
equation:
 2red =
1
⌫
X
i,k
Nk
 2
(p⇤i,k   pi,k,pred)2
pi,k,pred(1  pi,k,pred) (4.4)
 2red is measure of goodness of fit between observed RIAs and simulated RIAs, weighted
by the estimated variance. Using (4.4), a  2red of 10.49 was calculated, resulting a in
p-value close to 0. These results indicate the theoretical RIA did not fit the data well
based on using the multinomial sampling model.
To investigate the possibility of isotopic bias, the di↵erence between the measured
RIA and predicted RIA was plotted as a function of isotopomer mass state relative
to the base peak, denoted as  RIA(◆i). Figure 4.1, panel (B) shows the distribution
of  RIA(◆i) for rescaled mass isotopomers. If there were sampling bias for more abun-
dant isotopomers, one would expect that the mean  RIA(◆i) (referred to herein as
 ¯RIA(◆i)) would be significantly higher for isotopomers closest to the base peak, which
is observed in Figure 4.1, panel (B).
In summary, using a direct approach for the identification of peptides within an
unlabeled sample, we were able to identify precursor ion mass traces for all peptides
within the validation database. Due the high-rate of missannotation, our inability to
identify more than one isotopomer species per peptide and the existence of potential
overlapping MIDs, MIDs could be calculated for 75% (484/648) of peptides. However,
this recovery rate will improve when the software takes into consideration the e↵ects
of modifications as well as causes for missannotation.
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Figure 4.1: RIA and isotopic enrichment analysis for unlabeled E. coli : (A) simulated
RIAs using the calcuated average carbon label of 1.02% are plotted against measured
RIAs, (B) The di↵erence between simulated and measured RIA as a function of mass
isotopomer state scaled by the base peak (most abundant peak). Oversampling is
observed for the most abundant peak.
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4.2 7% Uniform Labeled E. coli
Software was validated with data containing well-defined isotopic enrichment; E. coli
was cultured under the same conditions described in Section 4.1 except in the presence
of 7% [U-13C6]-glucose described by Allen et al. (2013).
4.2.1 methods
The 484 peptides used for the quantification validation of unlabeled E. coli in Sec-
tion 4.1.2 were used for software validation on labeled data. This was done to ensure
that peptide MIDs for the validation set could be quantified from unlabeled material
and were not falsely identified.
Peptide features were generated using the parameter and protocol described in
Chapter 3 with a mass accuracy cuto↵ (MAC) of 20 ppm and a retention time window
(RTW) of ±2 minutes. The clustering algorithm used a dendrogram height cuto↵ of
2.5, and features were broken up into features containing contiguous isotopomer sets
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Figure 4.2: Cluster result example for labeled E. coli : Each block represents a mass
trace and rows and columns represent candidate features mass isotopomers, respec-
tively. The color gradient is a function of isotopic accuracy and opacity is a function
of the abundance of isotopologues.
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prior to annotation. Figure 4.2 is an example of the output provided by the clustering
algorithm for labeled samples, where each block represents a mass trace within a
potential feature. The row corresponds to a candidate feature for a peptide, while the
columns represent the mass isotopomer index for that mass trace. The color gradient
is a function of the isotopic accuracy while the opacity is a function of isotopologue
abundance. In this example, the true peptide feature is observed in the second row.
Without additional information, for labeled populations it would be impossible to
distinguish the true feature from other candidates. For example, Figure 4.2 shows
five candidate features, all of which are viable options if abundance and labeling are
unknown. On average, there were 8 candiate features for each peptide, with only 10
% of peptides (49/484) containing one unique feature.
Re-parameterizing MTC and RTW
To reduce the number of candidate features per peptide, visualizations analogous to
Figure 4.2 were generated for each peptide. It was observed that true features exhibit
higher mass accuracy than other candiate features. For example, filtering with a MAC
of 5 ppm would be su cient to remove all other candidate clusters in Figure 4.2.
Visualizations similar to Figure 4.2 were generated to encode both isotopic ac-
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Figure 4.3: Cluster result example for labeled E. coli : similar to Figure 4.2 except
color gradient in the figure below represents the di↵erence in retention time between
the reference precursor peak and the retention time of the mass trace. Features
denoted with an asterisk (*) represented the true feature for this peptide. In this
example, although the m/z values are very similar between two candidate features,
the true feature is much closter in retention time to precursor.
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curacy and retention time to find other distinguishing characteristics between true
features and other candidates. Figure 4.3 (A) and (B) show an example of the clus-
tering results, where the color gradient corresponds to mass accuracy and retention
in (A) and (B), respectively. While Figure 4.2 shows that features can be unique
determined when reducing the MAC, very similar candidate features exist in both
mass and isotopomer sets, but di↵er dramatically in retention time. To eliminate
candidate mass traces, the RTW was lowered to ±1 minutes.
The mean number of features per peptide was 8.3 at a mass accuracy cuto↵ of
20 ppm and retention time window of 4 minutes. However, once the mass accuracy
cuto↵ was lowered to 5 ppm and the retention time window was reduced to 2 minutes
the average number of features were reduced to 1.8, which allowed for the unique
identification of many more peptides.
Maximizing Recovery
After re-filtering mass traces with a MAC of 5 ppm and RTW of ±1 minute, candidate
features were determined by the clustering procedure described previously. Nearly all
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of the peptides contained at-least one feature while 53% (258/484) peptides contained
one unique feature per peptide. MIDs for the 258 unique peptide features were
quantified and average peptide carbon label was calculated using (4.1). A population
mean for all average peptide carbon label was calculated and used to simulate MIDs.
Unlike the methods described in Section 4.1, the mean average carbon label was
used to simulate MIDs for all peptides in the training set, and the base peak was
determined for each peptide. Candiate features were removed if they did not contain
the base peak, which resulted in 94% (454/484) of peptides containing one unique
feature while only 3% (13/484) of peptides had more than one feature containing the
base peak.
Quantification
RIAs were quantified and the average carbon label per peptide was calculated. For
the labeled dataset, 7 % (1525/21,476) of expected peaks were missing, and 40% of
scan events contained at least one missing peak. If the fitting procedure were not
employed, 18% (85/484) of peptides would not be quantifiable.
RIAs were simulated using a mean average carbon label of 6.68% and compared
to measured values. A nearly one-to-one relationship was observed with high and
significant correlation between simulate and measured RIAs (Slope: 0.99 and R2 :
0.98). However, multinomial sampling variance could not fully explain the observed
variance ( 2red = 8.31), much like results obtained from the unlabeled sample.
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(B) Measured RIA − Simuated RIA as a function of Isotopomer Enrichment
Slope: 0.999
Intercept: 0.0001
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Figure 4.4: RIA and isotopomer erichment analysis for uniformly labeled E. coli :
(A) simulated RIAs using the calcuated average carbon label of 6.68% are plotted
against measured RIAs, (B) The di↵erence between simulated and measured RIA as
a function of mass isotopomer state scaled by the base peak. Oversampling is not as
prenounced for the heavily labeled data set.
4.3 Labeled Soy Samples
The final software validation was performed data from the peptide-based metabolic
flux analysis of soy seeds. The data were generated under the same experimental
conditions as listed in Section 3.1, except chymotrypsin was used for protein digestion
instead of trypsin. MaxQuant was able to identify 19 proteins from 193 peptide
spectra.
Recovery Results
Mass traces were filtered using a 5 ppm MAC with a RTW of ±1 minute. A den-
drogram height cuto↵ set to 2.5. Peptides were kept if there was one unique feature
remaining. 34% (66/193 , 966 mass isotopomers) of peptides were quantified, with
11/19 proteins containing at least one measurable peptide. MIDs were quantified and
the average carbon label was determined to be 23.3%. The mean carbon label was
then used to simulate base peaks for all 193 peptides in the original database and
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second search was performed. Candidate features were further reduced by requiring
the existence of the simulated base peak. The number of quantifiable peptides in-
creased by 42% (29/193) resulting in a final recovery rate of 49%. 74% of proteins
had at least one measurable peptide (14/19) while a total of 1426 mass isotopomer
RIAs were quantified.
Quantification
To test the quantitative capabilities for flux-dependent labeling samples, the extracted
RIAs were compared to simulated RIAs using deconvolution derived amino acid MIDs
generated by Mandy et al. (2013). Amino acid MIDs (AAMDs) were determined for
peptides in the training set originating from soy storage proteins glycinin and beta-
conglycinin. AAMDs were calculated using flux-constrained deconvolution described
in Section 1.3.3.
51 peptides were extracted from glycinin and beta-conglycinin from the chy-
motrypsin digestion data set, and simulated RIAs were generated by first simulating
the labeled and unlabeled isotopologue populations, then mixing the populations us-
ing the optimized ratio. The labeled population was derived by convolving optimized
AAMDs from flux-constrained deconvolution, while the unlabeled population was
generated by convolving natural elemental distributions. The labeled population was
then mixed with 2.23% unlabeled, original biomass. Simulated and measured RIAs
were normalized and weighted linear regression was performed, where each RIA was
weighted by the total number of ions. Figure 4.5 show a nearly one to one relationship
between predicted and measured RIA’s (Slope: 0.95, R2: 0.88).
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Figure 4.5: Simulated vs. measured RIA in Soybean: RIAs were simulated by con-
volving AAMDs generated by flux-constrained deconvolution of the training set fol-
lowed by mixing in 2.23% of unlabeled isotopologues.
0 0.05 0.1 0.15 0.2 0.25 0.3
0
0.05
0.1
0.15
0.2
0.25
0.3
simulated fractional enrichment
m
e
a
su
re
d 
fra
ct
io
na
l e
nr
ich
m
en
t
 
 
Slope: 0.95
Intercept: 0.0033
R2: 0.88
4.4 Summary
The extraction of unlabeled, uniformly labeled and flux dependent labeled data sets
were demonstrated high accuracy and recovery. Visualizations were used to optimize
extractions for labeled datasets: a MAC of 5 ppm and a RTW of ±1 minute was
observed to su ciently reduce the number of candidate features. This resulted in
approximately 50% of peptides with one unique feature, allowing for the calculation
of RIAs and average carbon label. Using the unsupervised approach discussed in Sec-
tion 4.2 to estimate base-peaks for the peptide set, peptide feature recovery increased
by 50% for both labeled data sets, resulting in recovery rates of 94% and 49% for
uniformly and flux-dependent labeled samples, respectively. The high occurrence of
missing data was demonstrated for labeled data sets, highlighting the need for fitting
RIAs to measured data. The quantification method produced estimated RIAs that
showed extremely high similarity and correlation with simulated values.
Chapter 5
Discussion and Future Work
In Chapter 4, the quantification capabilities were investigated using unlabeled data
prior to automated extraction. Measured RIAs were shown to be very similar to
simulated RIAs. However, the multinomial sampling variance did not fully explain
the experimental variance based on the reduced chi-squared test, which could be
attributed to instrument or signal-dependent variance, or the observed sampling bias
for highly abundant peaks.
The use of automated extraction of PMDs from uniformly labeled and flux-
dependent labeled experiments were demonstrated with 94% and 49% recovery rates,
respectively. Furthermore, the quantification of uniformly labeled data showed a
slightly better fit to simulated RIAs and reduced observed sampling bias. In all cases,
nearly one-to-one relationships were observed between simulated and measured RIAs
with strong correlation.
In this section software and experimental approaches are discussed for improving
identification rates and feature annotation, followed by the experimental approaches
for improving RIA quantification and error estimation. The final section touches
on the software and interactive visualization tools that will provided to biological
community.
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5.1 Software Improvements
5.1.1 Identification
Roughly 75% of peptides identified from MaxQuant were quantifiable using our soft-
ware implementation. The largest reason for why peptides were not quantified were
missannotations within the peptide database. Missannotations can be improved by
developing a workflow that integrates other peptide identification search software to
corroborate the existence of the peptide. Furthermore, incorporating the possibility
of modifications results in a larger false discovery rate for tandem MS-MS (fragmen-
tation) based identification approaches (Mallick and Kuster, 2010). Additionally,
the percentage of precursor ions sequenced in any proteomic experiment represents
only a subset of peptides within the sample. As instruments provide improved mass
resolution, accuracy and signal dynamic range for LC-MS, non-fragmentation based
identification methods could be used to corroborate sequenced based methods and
reduce the rate of false positives.
Another factor for why peptides were not quantified was that isotopomers other
than precursor mass isotopomer was not observed. This was most likely attributed
to the low abundance of the precursor, but has not been investigated.
Lastly, peptides were not quantified when an intense and highly correlated peak
was observed in the m 1 state. Although the loss of discrete molecular groups from
the peptides are commonly observed (e.g. neutral loss), intense peaks in the the m 1
state are often not observed. Thus, the observation of intense peaks in the m 1 state
are potentially caused by overlapping MIDs from other molecular species. However,
better characterization of the probability associated with neutral loss in peptides will
allow for improved detection of potential contaminations.
Currently, the software does not take into consideration the score provided by the
identification software. We investigated the use of the score by comparing the mean
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scores of quantifiable peptides for the unlabeled E. coli with the mean scores of pep-
tides that were not quantified. However, only a slightly higher score for quantifiable
peptides was observed.
5.1.2 m/z Calibration
The m/z domain was shown to exhibit a significant amount of drift throughout a
single LC-MS experiment. To correct for this, a simple ”lock” mass calibration used
in traditional proteomic experiments should be employed for labeled data. By using
a standard that is injected into the mass analyzer, the software could rescale each
scan in the m/z domain. Using a calibrant will allow for smaller isotopic precision
cuto↵, subsequently increasing isotopic similarity between mass isotopomers.
It was also observed that the isotopic precision between mass traces could be
dependent on the absolute di↵erence in m/z. This e↵ect is most likely attributed to
a potential space charging e↵ect, where intensely charged groups of isotopomers
repel one another, resulting a larger measured di↵erence in m/z. Approaches for
correcting for this e↵ect have been proposed, but are not implemented within the
software (Gorshkov et al., 2010).
5.1.3 Feature Annotation
In order to distinguish between candidate features for a peptide, additional infor-
mation for which isotopomers are more likely to be observed is required. From Sec-
tion 4.2 and Section 4.3, requiring the feature contain the most likely peak based on
a simulated distribution increased recovery rates by 50%. The approach that worked
best was to simulate a base peak using the mean label enrichment within subset of
the data, followed by requiring feature candidates to contain the simulated base peak.
This approach works best for larger peptides due to the central limit theroem. As pep-
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Figure 5.1: Using Average Carbon Label to Simulate PMDs: MIDs were simulated
by convolving either non-uniformly labeled AAMDs (blue bars) or uniformly labeled
elements (red bars). All distributions contain the same average carbon label of 38%.
The simulated base peaks are equivalent for the longer peptide (B), but not for the
short peptide (A)
tide length increases, the PMDs are constructed from a larger number of AAMDs.
As a consequence, the PMD approaches a unimodal, normal distribution with a base
peak that approaches the base peak of a uniformly labeled peptide. This e↵ect is
illustrated in Figure 5.1 for peptides AG and AGAGAGAGAG, both with an average
carbon label of 38%.
If the investigator was interested in obtaining smaller peptides, an experimental
approach is suggested in Figure 5.2. The investigator runs two experiments, one de-
signed to produced flux dependent PMDs and the other from unlabeled (uniform and
naturally abundant) substrate. Material from both conditions are mixed using a fixed
ratio. MS spectra are collected from the mixed sample as well as an unlabeled sample,
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Figure 5.2: Experimental Design Example: Spiking with Known PMDs: Biomass is
grown seperately using uniformly labeled substrate and substate that provides flux
information. Both are mixed and the software uses the basepeak of the uniformly
labaled PMD to identify the feature.
and a base peak is calculated from the average label within the the unlabeled sample.
The software uses this base-peak as annotation criteria for the mixed sample. Using
the fixed ratio between unlabeled and flux-labeled biomass, the unlabeled population
is then subtracted from the labeled population (see Section 1.3.1).
Lastly, the feature annotation method makes no attempt to distinguish true from
false annotations. Falsely annotated features could be observed using the reduced chi-
squared residuum per for each peptide to remove PMDs with significantly di↵erent
average carbon label. For example, the peptide with the largest chi-squared residuum
had a 2.8% average carbon label in the 7% uniformly labeled data set. This suggests
that false positives might be detectable using the outliers in the chi-squared residuum
for uniformly labeled experiments or the objective function in PMD optimization
scheme for flux-labeled experiments.
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5.2 Quantitative Capabilities
In addition to the feature identification improvements previously discussed, the quan-
titative capabilities of our methods should be compared to current practices. Addi-
tionally, new statistical models can be developed that potentially could account for
the additional variance described in Chapter 4
5.2.1 RIA Estimation
Section 3.5 describes a new method for quantifying MIDs using LC-MS data. The
model assumes that missing peaks are primarily attributed to software limitations
within the pipeline, ranging from collecting data from the mass analyzer to prepro-
cessing of peaks using low isotopic precision cuto↵s, rather than that the signal was
below the limit of detection. This was motivated by the fact that for non-observed
peaks, the number of isotopologues at the limit of detection was more than three
standard deviations less than the expected number of isotopologues. However, an
established statistical method for distinguishing between peaks below the limit of
detection and missing peaks has not been demonstrated.
The rate of missing peaks is a function of the isotopic precision specification within
the software. In Section 3.5, the feature matrix is filtered prior to quantification based
on the isotopic precision for each m/z measurement. If this parameter is too small,
completely valid peaks might be artificially removed from the feature matrix. The ro-
bustness of the quantification algorithm has not been throughly tested to demonstrate
the performance as a function of isotopic precision.
Lastly, the quantification algorithm has not yet been compared to current meth-
ods of calculated RIAs. RIAs are typically quantified by determining the fractional
abundance of each isotopomer over a retention time range. We have initially observed
slightly better fits between simulated RIAs and measured RIAs using the fitting ap-
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proach over current methods. However, this analysis could be inherently biased be-
cause the simulated model uses an average carbon label calculated from fitted RIAs.
Unbiased tests are currently being devised to compare these quantification methods.
5.2.2 Variance Estimation
Currently the most sophisticated statistical model of mass high resolution LC-MS
data is based on the multinomial distribution, which assumes that sampling occurs
with replacement. In this model, the observed signal is assumed to come from a small
fraction of the total population of isotopologues from the experiment. However, in
reality LC-MS can be thought of as two sampling events: (1) the sample from the
experiment to the LC column, and (2) the sampling from the LC to the mass analyzer.
While (1) would still come from a multinomial distribution, (2) would come from a
hypergeometric distribution. At each scan event, a sample of isotopologues are drawn
from the finite number of isotopologues that exists on the column. Each subsequent
scan event then samples from the remaining set of isotopologues, which is smaller
than the previous scan event. Currently, the model assumes that each scan event
samples from the same population of isotopologues. More accurate estimation of
measurement variance could be derived using a model such as this, however has not
been tested.
5.3 Future Work
In addition to software that was developed for the extraction and quantification of
PMDs, a substantial work went into developing new visualization tools to explore
mass spectrometry data and the output at each stage of our method. For example,
Section 4.2 demonstrates the use of flexible visualization for software development
and data analysis, aiding both the parameterization and troubleshooting process. In
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Figure 5.3: interactive mass spectromtery web-page screen shot: raw data reduced at
any stage of the algorithm can be loaded and visualized interactively
addition to making software available, there will be an online visualization toolkit
allowing the user to explore their data sets at each stage of the processes. Figure 5.3
is an example screenshot from a web-interface currently in development. This data
set was generated after peaks had been grouped into mass traces, but before features
had been identified. Having access to easy-to use and intuitive visualization tools
such as this will give the user a better understanding of their data.
The workflow shown in Figure A.1 will initially be implemented as modular pieces
of MATLAB scripts and functions. The code will be cleaned, commented and hosted
on and online project hosting page, such as GitHub. After debugging and code
optimization, the software will be compiled and hosted by an online bioinformatics
platform such as Galaxy.
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Appendix A
Software Design
A.1 File Preparation
Because many programs contain di↵erent data formate requirements, it is important
to describe the correct formats for each data sample one would obtain in this work-
flow. Msconvert (ProteoWizard) was used to convert thermo .RAW files to mzXML
files. Vendor supplied centroided peaks were used within the peak picking algorith.
Additional parameters used with msconvert are provided in the software package.
Figure A.1 shows the file flow at each stage of the procedure. The files ending in
MAT are data structures within MATLAB.
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Experiment
13C-labeled 
Experiment
MaxQuant
feature finder
.RAW 
.mzXML
msconvert
maxquant output parser
msms.txt
peptide.txt
proteinGroups.txtthermo raw file parser
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openMS
.featureXML
 openMS exporter
(python)
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.RAW 
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.featureMAT 
mid quantification
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Figure A.1: Detailed software design flow and file formats:
Appendix B
Statistical Interpretation of Mass
Isotopomers
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For a given peptide, i, we can define every observed isotopomer as a random
variable, Xi, drawn from a finite sample space,  i consisting of all possible mass
isotopomers, Ni. The discrete probability of drawing mass isotopomer j is Pr{Xi =
j}, where j 2  i = {0, 1, . . . , N 1}. From this point further, we will use the notation
pi,j ⌘ Pr{Xi = j} for clarity.
NiX
j
pi,j = 1 (B.1)
B.1 Quantification of Isotopomer Ion Counts
For the ith peptide in our measurement set, we can estimate the number of ions
for isotopomer j, Ii,j, from the absolute peak intensity and noise, Si,j, and Ni,j,
respectively, using the following equation:
Ii,j =
Si,j
Ni,j
K
q
R
R0
zi
(B.2)
whereK is the noise band, R is the resolution setting and R0 is the reference resolution
setting for time-dependent acquisition.
We can extend our ion count estimate, Ii,j, to include an additional index, k, which
corresponds to the retention time, or scan event, associated with that measurement.
Therefore, the total number of ions for a particular isotopomer in a given peptide is
given by
sMX
k=s1
Ii,j,k = Ii,j 8i, j (B.3)
where {s1 . . . sM} is the set of scans that contain the jth isotopomer of peptide i.
Furthermore, it is convenent to define the set of all measuremed isotopologue for
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peptide i by Ii =
P
j Ii,j.
We can estimate the probability of sampling isotopomer j for peptide i, Pr{Xi =
j}, by taking
Pr{Xi = j} = Ii,jP
j Ii,j
=
Ii,j
Ii (B.4)
where
P
j Ii,j is the total number of ions for all isotoplogues for peptide i. This
procedure is analogous to summing all ions observed for a particular isotopomer and
dividing by the total number of isotopologues extracted for that peptide within the
scan event set Si = {s1 . . . sM}. This enables us to generate an expected value,
E(Xi = j) of sampling the jth isotopomer in peptide i for any sample size, ⌘, such
that
E(Xi = j, ⌘) = ⌘ Pr{Xi = j} = ⌘ Ii,jP
j Ii,j
(B.5)
B.2 Isotopomer Ion Counts as Random Multino-
mial Samples
It was proposed that the observed sampled isotopologue population is equivalent to a
multinomial distribution. The multinomial distribution is an extension of the binomial
distribution, where independent trials (observation of a single mass isotopomer ion)
leads to success in exactly one of many categories (i.e. sampling mass isotopomer
m+0).
This is relevant because this represents the physical sampling of the total pop-
ulation of isotopologues within the cell. Assuming that the observed group of iso-
topologues are only a fraction of the total population within the cell, the multinomial
distribution generalization allows us to calculate variances and covariances for mea-
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sured sampling probabilities for each isotopomer.
Extending from Appendix B.1, if the sampling of isotopomer j has probability
pi,j, we define the expected value as:
E(Xi = j) = Iipi,j (B.6)
with variance and covariance defined as:
Var (Xi = j) = Iipi,j(1  pi,j) (B.7)
Cov (Xi = j,Xi = k) =  Iipi,jpi,k (j 6= k) (B.8)
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Feature matricies for the training data are shown in Figure C.1 while cluster
results are shown in Figure C.2.
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Figure C.1: Feature Matrix: training data
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Figure C.2: Candidate Feature Sets: training data
Appendix D
Validating RIA LC Bias
In order to investigate whether there was an isotope bias within the LC domain,
we extracted peptide envelopes for 600 peptides from an unlabeled E. coli sample.
For each peptide, all isotopomers were extracted using the procedure described in
Appendix B.1. However, instead of summing all ions for each isotopomer across
all scans, isotopomer distributions were calculated for each scan event. Relative ion
abundances, b, were then generated by dividing the raw ion count by the total number
of ions extracted for that scan, such that
bi,j,k = Pr{Xi,k = j} = Ii,j,kP
j Ii,j,k
(D.1)
For the jth isotopomer, we are interested in how bi,j,k changes at each scan event
in time. For clarity, we can arrange bi,j,k into a the column vector bi,j, where the
kth element in the vector is the relative isotope abundance for the jth isotopomer of
peptide i at scan k. Additionally, we transform the scan index into retention times
through the function R(sk), because scan events are not necessarily equally spaced in
time.
A weighted linear regression was performed by attempting to find parameters ↵i,j
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and  i,j, such that
bi,j,1 = ↵i,jR(s1) +  i,j
bi,j,2 = ↵i,jR(s2) +  i,j
... =
...
bi,j,M = ↵i,jR(sM) +  i,j
(D.2)
Or, in matrix notation:
bi,j = Ai,jxi,j Ai,j =
0BBBBBB@
R(s1) 1
R(s2) 1
...
...
R(sM) 1
1CCCCCCA xi,j =
0@↵i,j
 i,j
1A (D.3)
Because each equation in (D.2) comes from from scans consisting of di↵erent sam-
ple sizes, Ni,k, we perform a weighted linear regression for solving (D.2) using the
weighting matrix, Wi, such that
Wi =
0BBBBBB@
Ni,s1 0 . . . 0
0 Ni,s2 0 0
... 0
. . .
...
0 0 . . . Ni,sM
1CCCCCCA (D.4)
The optimal solution for parameters stored in xi,j is thus
x⇤i,j = (A
T
i,jWiAi,j)
 1ATi,jWibi,j (D.5)
Each optimal slope parameter, ↵⇤i,j, was then compared to adjacent heavy and light
isotopomers for peptide i. For example, if peptide i contained three isotopomers of
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Figure D.1: Histogram of Weighted RIA Slope Di↵erences:
mass {m+ 0,m+ 1,m+ 2}, we would measured the di↵erence in ↵⇤i,j between m+1
and m+0, as well as between m+2 and m+1. This was done because if there were an
isotope bias, where heavy isotopes eluted o↵ the column slower than lighter isotopes,
we would observed distributions enriched with heavier isotopes in later scans. This
would result in a paired di↵erence in ↵⇤i,j that is greater than zero.
All paired di↵erences in ↵⇤i,j are displayed in Figure D.1. A one-sample t-test was
performed to demonstrate that the paired di↵erences come from a normal distribution
and have a mean of zero. The t-test resulted in a p value of 0.53 with a mean and
standard deviation of of  0.0016 ± 0.1115 (CI:[ 0.0067, 0.0034], DF: 1822), which
provides no reason to infer that the data do not come from a normal distribution with
a mean of zero. Thus, there is no observable isotope e↵ect for RIA quantification.
